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Social experiences including discrimination, low social support, and interpersonal 
conflict are reliable predictors of depression symptom severity (Costello, 1982; Monroe, 
Rohde, Seeley, & Lewinsohn, 1999; Phifer & Murrell, 1986). However, individual 
differences may buffer against or exacerbate risk (Pluess & Belsky, 2015). A more 
holistic and dimensional approach, in line with modern perspectives on mental health 
(Kircanski, LeMoult, Ordaz, & Gotlib, 2017), requires an investigation of individual 
differences that moderate associations of positive and negative social experiences with 
depression symptom severity. This dissertation assesses relative contributions of social 
experiences (low social support, discrimination, childhood trauma, and sexual 
objectification) to variation in depression symptom severity and how social 
responsiveness traits (rejection sensitivity, need to belong, self-monitoring, dispositional 
empathy, alexithymia, and a Social Responsiveness latent variable) moderate these 
associations in a sample of 1,128 college students. It also includes a systematic review of 
the role of oxytocin system genetic variation in depression. Evidence from the review 
informed creation of a polygenic score of variation associated with higher oxytocin 
neurotransmission which was tested in association with depression symptom severity and 
social responsiveness traits in a sample of 1,022 college students. Discrimination and 
perceived social support were most strongly associated with depression symptom severity 
and these associations were moderated by rejection sensitivity, alexithymia, and a Social 
Responsiveness latent variable. Oxytocin system genetic variation was not associated 
with depression symptom severity or social responsiveness traits. The polygenic score 
moderated an association between net social experiences and depression symptom 
severity, but this effect did not survive Bonferroni correction or tests for moderation of 
individual social experiences. Results strengthen and expand upon theories of resilience 
and susceptibility and may inform individualized treatment for depression symptoms, 
including interventions focused on social cognition (Masi, Chen, Hawkley, & Cacioppo, 
2011) and healing from discrimination (Comas-Díaz, 2016). Results align with evidence 
suggesting genetic variation in the oxytocin system is not robustly associated with 
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CHAPTER 1: INTRODUCTION 
Depression is a complex disorder with a wide variety of symptom profiles, 
genetic risk factors, and experiential risk factors (Fried & Nesse, 2015). Depression 
remains one of the primary health concerns in the United States (Machado et al., 2018) 
and the lack of a comprehensive understand and challenge of finding effective treatments 
has become increasingly urgent as prevalence rates have increased threefold during the 
COVID-19 pandemic (Ettman et al., 2020). Subclinical symptoms of depression also 
impact well-being, and investigating the full range of depression symptom severity can 
provide richer information regarding the spectrum of depression-related issues (Deroma, 
Leach, & Leverett, 2009). Individual treatment of depression would benefit from 
identifying specifically the combinations of individual differences and social experience 
that are most strongly associated with depression symptom severity. 
A variety of social experiences including social support (Werner-Seidler, Afzali, 
Chapman, Sunderland, & Slade, 2017), interpersonal trauma (Humphreys et al., 2020), 
and relationship conflict (Holley, Haase, Chui, & Bloch, 2018) are strongly and reliably 
associated with depression symptom severity. However, individual differences in 
responses to these social experiences are not well understood. Certain traits and genetic 
variants have been identified that interact with specific experiences in association with 
depression symptom severity (Arnau-Soler et al., 2019). However, a comprehensive 
investigation into what specific combinations of individual differences and social 
experiences play the greatest role in depression symptom severity has not been done.  
Genetic variation in the oxytocin system is associated with depression and 
responsiveness to certain social experiences; however, the evidence is weak and unclear. 
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The association between genetic variation in the oxytocin system and depression, as well 
as social responsiveness, suffers from not compiling multiple variants, not considering 
different types of social experiences, and commonly low sample size (Dick et al., 2015). 
Considering a wider variety of social experiences and using a polygenic measure of 
oxytocin genetic variation in a large sample size may help clarify a role of genetic 
variation in the oxytocin system in depression symptom severity. Large samples and 
polygenic approaches are crucial for detecting the small effect sizes of genetic variation 
on complex behavior traits, so research addressing this limitation of previous evidence 
provides stronger evidence for whether genetic variation in the oxytocin is associated 
with depression and social responsiveness (Chabris, Lee, Cesarini, Benjamin, & Laibson, 
2015). 
Theoretical Basis 
This work is strongly grounded in theories within social psychology, personality 
psychology, and neurobehavioral sciences. There is ample support for the crucial role of 
social experiences in well-being, considering humans rely on a sense of belonging 
(Castro & Pacherie, 2020). Multiple theories specifically consider the role of social 
support in well-being, including the main effect hypothesis that suggests higher social 
support is directly associated with higher well-being, and the buffering hypothesis that 
suggests social support mitigates some of the harmful effects of stress on well-being 
(Zhang, 2017). Both theories emphasize the importance of social support and related 
constructs in elements of well-being, including depression symptom severity. 
When investigating interaction effects, it is important to consider theories 
describing the nature of the interactions. Diathesis-stress describes situations in which a 
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trait or genetic factor may increase the risk of a negative outcome (such as increased 
depression symptom severity), but only in the presence of negative environmental factors 
(Rosenthal, 1963). Vantage sensitivity describes situations in which the trait or genetic 
factor may increase the likelihood of a positive outcome (such as low depression 
symptom severity), but only in the presence of positive environmental factors (Pluess & 
Belsky, 2015). Differential susceptibility describes situations in which a trait or genetic 
factor is associated with a more negative outcome in the presence of negative 
environmental factors and a more positive outcome in the presence of positive 
environmental factors (Pluess & Belsky, 2009). 
When considering the role of genetic variation in the oxytocin system in 
depression symptom severity in context of social experience, the social theories of 
oxytocin are pertinent. The prosocial theory suggests that increased oxytocin levels and 
oxytocin neurotransmission increase prosocial behaviors, and aligns with evidence 
associating higher oxytocin with more trust (Declerck, Boone, Pauwels, Vogt, & Fehr, 
2020; Kosfeld, Heinrichs, Zak, Fischbacher, & Fehr, 2005), affection (Kortesluoma & 
Karlsson, 2011) and maternal care (Pedersen & Boccia, 2002). The social salience theory 
(Shamay-Tsoory & Abu-Akel, 2016) suggests that because sometimes oxytocin’s 
correlates are antisocial, such as aggression (Bosch, Meddle, Beiderbeck, Douglas, & 
Neumann, 2005) and ethnocentrism (De Dreu, Greer, Van Kleef, Shalvi, & Handgraaf, 
2011), the neuropeptide’s role is primarily to increase attention to social stimuli. This 
theory is supported by evidence of increased attention to faces in people administered 
oxytocin. The social approach theory also addresses the antisocial behaviors connected 
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with oxytocin, by explaining oxytocin’s role as increasing social approach behaviors, 
whether they are affiliative or aggressive (Shamay-Tsoory, 2010).  
Filling Gaps in the Research 
Most studies showing interactions between social experiences and individual 
differences only include one experience variable and few individual differences, 
preventing a comprehensive investigation of the specificity or generalizability of these 
interactions. Furthermore, many studies do not include enough range in social experience 
to test for differential susceptibility (Pluess & Belsky, 2009). We also investigated a 
latent variable of Social Responsiveness to consider potential underlying factors 
including biology that might be shared among traits that interact with social experiences. 
For these reasons, we conducted a study investigating connections among perceived 
social support, childhood trauma, perceived discrimination, sexual objectification, 
rejection sensitivity, alexithymia, need to belong, self-monitoring, and dispositional 
empathy with depression symptom severity. Each of these variables is described in the 
methods section of Chapter 2. 
Among the unclear findings regarding potential roles of genetic variation in the 
oxytocin system in depression, there is not a review to weigh the evidence. There is a 
review of the association between endogenous oxytocin and depression (Engel, Laufer, 
Knaevelsrud, & Schumacher, 2019), a review of oxytocin genetic variation associated 
with social behavior (Kumsta & Heinrichs, 2013), and an older review of general genetic 
variation associated with depression (Levinson, 2006), but none specifically connecting 
genetic variation in oxytocin system with depression. We conducted this review to 
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identify what genetic variants in the oxytocin system are the best candidates for further 
investigation using a polygenic score. 
The evidence regarding associations between genetic variation in the oxytocin 
system and depression symptom severity still needs a high-powered study that uses a 
polygenic approach and considers a variety of different social experiences. We conducted 
a study using a polygenic score with 10 oxytocin-related SNPs, a continuous measure of 
depression symptom severity, and considering the context of perceived social support, 
childhood trauma, perceived discrimination, and sexual objectification. We also 




CHAPTER 2: REJECTION SENSITIVITY, ALEXITHYMIA AND A GENERAL 
SOCIAL RESPONSIVENESS FACTOR MODERATE PERCEIVED SOCIAL 
SUPPORT AND DISCRIMINATION IN ASSOCIATION WITH DEPRESSION 
SYMPTOM SEVERITY 
Abstract 
This study investigated relative contribution of social experiences (i.e. perceived 
social support, perceived discrimination, childhood trauma, sexual objectification) to 
depression symptom severity and whether social responsiveness traits (rejection 
sensitivity, need to belong, dispositional empathy, self-monitoring, alexithymia) 
moderated these associations. 1,128 undergraduates completed questionnaires.  Perceived 
discrimination and perceived social support were the strongest predictors of depression 
symptom severity. The association between higher perceived social support and lower 
depression symptom severity was stronger in people with higher rejection sensitivity or 
higher alexithymia. Perceived social support and perceived discrimination were both 
more strongly associated with depression symptom severity for people with higher Social 
Responsiveness, a latent variable comprised of rejection sensitivity, need to belong, 
dispositional empathy and self-monitoring. Results emphasize the importance of focusing 
on perceived social support and discrimination in people suffering with depression 
symptoms. Further investigation of the biological and other underlying elements of the 




Rejection sensitivity, alexithymia and a general social responsiveness factor moderate 
perceived social support and discrimination in association with depression symptom 
severity 
Depression is a complex disorder with more than 1,000 unique symptom profiles 
(Fried & Nesse, 2015), and risk factors vary from genetics and prenatal environment to 
cognitive tendencies and life events (Rush, 2007). Depression has high mortality and 
morbidity and impacts more than 16 million adults in the United States based on National 
Survey on Drug Use and Health data (2019). College students are at approximately 3 
times the risk of the average adult, with an estimated 30.6% of University students 
reporting struggling with depression compared to about 10% of the general population 
(Ibrahim, Kelly, Adams, & Glazebrook, 2013). Limiting investigations of depression to 
the presence or absence of a diagnosis fails to capture concerns related to subclinical 
depression symptoms and variation in symptom profiles (Rush, 2007). The current study 
investigates depression symptom severity (a cumulative score of number and intensity of 
symptoms) in university students in context of social experiences and individual 
differences, using a dimensional approach which provides richer information than a 
categorical assessment and is particularly important when trying to capture intricacies 
such as statistical interactions (Kircanski et al., 2017).  
Focusing research and wellness efforts on only people who meet criteria for a 
depression diagnosis neglects that more than twice the number who meet diagnostic 
criteria are impacted by subclinical depression symptoms (Cuijpers et al., 2004). 
Subclinical depression symptoms can lead to 2-3 times higher risk for major depressive 
disorder later in life (Pine, Cohen, Gurley, Brook, & Ma, 1998), increased risk for 
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substance abuse (Sofuoglu, Brown, Babb, & Hatsukami, 2001), difficulties in social 
adjustment and self-efficacy, lower academic performance (Deroma et al., 2009), and 
lower life satisfaction (J. I. Lee, Kim, & Oh, 2003). Researchers and clinicians 
acknowledge the importance of experiences and traits in the development of depression, 
but there is a need for a comprehensive integration of how these factors work together, in 
line with efforts toward a more holistic and dimensional approach of mental health 
(Kircanski et al., 2017).   
Social Experiences are Associated with Depression Symptoms 
Poor social support, social losses (death, divorce, etc.), and social isolation are 
strong and reliable predictors of depression (Monroe et al., 1999; Phifer & Murrell, 1986; 
Santini, Koyanagi, Tyrovolas, Mason, & Haro, 2015). However, relative contribution of 
different types of social experiences are rarely investigated together, and individual 
differences in responses to social experiences are not well understood.  
Different theories posit different mechanisms explaining connections between 
social experiences and individual differences in responsiveness to social experiences in 
association with depression symptoms. The buffering hypothesis of social support 
suggests that social support exerts beneficial effects by lessening negative effects of 
stressful experiences. The main effect hypothesis of social support suggests that social 
support has a direct effect on increased well-being, regardless of stress (Cohen & Syme, 
1985). Evidence supporting both the buffering hypothesis (Fredrick, Demaray, Malecki, 
& Dorio, 2018) and main effect hypothesis (Werner-Seidler et al., 2017) suggests that 
while social support may have some general benefits across contexts, it is also important 
to consider interactions with other social experiences.  
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As important as social support is for reducing symptoms of depression, unfair 
social treatment can significantly increase depression symptom severity. Discrimination 
based on a variety of traits including race (Powell, Banks, & Mattis, 2017), gender (Kim 
& Park, 2018) sexual orientation (Wyman Battalen et al., 2020), and weight or 
appearance (Hunger, Dodd, & Smith, 2020) is associated with depression. Discrimination 
in the form of microaggressions, incivility, hostility, harassment, and providing lesser 
opportunities or services can negatively impact well-being via elevated stress, anxiety, 
depression (Woodford, Han, Craig, Lim, & Matney, 2014) and related health disparities 
(Williams & Mohammed, 2009). Discrimination for any reason can be harmful, and 
people in disadvantaged groups face greater exposure to multiple forms of discrimination, 
which is associated in a dose-dependent manner with incrementally worse health 
(Grollman, 2012). 
Self-objectification (the tendency to overemphasize the importance of physical 
traits in self-worth) is reliably associated with depression (Jones & Griffiths, 2015). 
Because objectification theory (Fredrickson & Roberts, 1997) attributes self-
objectification partially to interpersonal sexual objectification women experience in a 
culture that habitually reduces their value to physical aesthetics, sexual objectification is 
another likely candidate to contribute to depression symptom severity.  
Traumatic early life social experiences can also have lasting impact on depression 
later in life. Childhood emotional abuse, neglect, sexual abuse, domestic violence, and 
physical abuse are all associated with higher risk of depression in adulthood (Mandelli, 
Petrelli, & Serretti, 2015). 
Marginalized Identities and Depression Symptoms 
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 Identifying as a member of a marginalized group is associated with increased 
social stressors that contribute to symptoms of depression (Woodford, Han, Craig, Lim, 
& Matney, 2014). Risk associated with disadvantaged group membership may be 
partially, but not completely explained by discrimination-related stress. Depression 
diagnosis occurs in relatively comparable rates across many racial and ethnic groups; 
however, disparities in treatment availability may make minority groups more vulnerable 
(Simpson, Krishnan, Kunik, & Ruiz, 2007). There is some evidence for higher depression 
risk among people who identify as a sexual minority as well as higher depression rates in 
women (Marshal et al., 2011). However, there is also evidence in women veterans that 
although women with either a sexual or racial/ethnic minority status had elevated 
depression and anxiety risk, those who were both racial/ethnic and sexual minorities had 
lower risk (Lehavot, Browne, & Simpson, 2014). This reflects complexity in the 
relevance of marginalized identity membership, such that in some contexts there is 
evidence of developed resilience in people with multiple marginalized identities. 
Social Responsiveness Traits and Depression Symptoms 
Some traits related to resilience or social responsiveness moderate the effects of 
positive experiences such as social support on depression (Ağır, 2019) while others 
moderate effects of negative experiences such social stress (Niu, Sun, Tian, Fan, & Zhou, 
2016). However, most studies only investigate a single trait interacting with a single type 
of experience, and a unified investigation of how both positive experiences and negative 
experiences interact with a variety of social responsiveness traits is necessary to 
understand the specificity of these effects and test for differential susceptibility (Pluess, 
Stevens, & Belsky, 2013). The current study investigates depression symptom 
11 
 
associations with perceived social support, perceived discrimination, childhood trauma, 
and sexual objectification in context of rejection sensitivity, need to belong, dispositional 
empathy, and self-monitoring, which are further described in the methods section.  
Social Responsiveness as a Unified Trait  
Rejection sensitivity, need to belong, dispositional empathy, self-monitoring, and 
alexithymia are conceptually similar in capturing individual differences in how sensitive 
people are to perceiving and responding to social cues. Trait resilience is conceptualized 
as an individual difference that is protective against depression risk (Waugh, Thompson, 
& Gotlib, 2011), and traits such as social exclusion sensitivity and negativity bias 
exacerbate environmental risk (Williams & Happé, 2010). However, capturing an 
underlying factor explaining connections among these variables to measure a general 
responsiveness to social experiences requires measuring several related social 
responsiveness traits and creating a latent construct.  
It has not yet been investigated whether social responsiveness variables group 
together as dimensions of the broader construct of Social Responsiveness, which is 
consistent conceptually with the identified common biological mechanisms that have 
been implicated in these traits. For instance, differential functioning of both the oxytocin 
system and hypothalamic pituitary axis have been implicated in responses to social 
stressors (Heinrichs, Baumgartner, Kirschbaum, & Ehlert, 2003), alexithymia (Kirsch, 
2015), and empathic responsiveness (Norman et al., 2012). Therefore, these traits may be 
effective for predicting the impact of social experiences on depressive symptoms when 
used as indicators of a latent construct. This study also tests traits separately, to allow for 
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the possibility that there is more specificity in which traits interact with social 
experiences and which do not.  
Diathesis Stress, Vantage Sensitivity and Differential Susceptibility 
The diathesis-stress model describes preexisting (often biological, trait-based) risk 
for a disorder that only confers risk when stress exacerbates that risk (Rosenthal, 1963). 
The diathesis-stress model has been applied across a variety of individual differences 
including genetic variation (Rende & Plomin, 1992) and personality traits (Kendler, 
Kuhn, & Prescott, 2004), and environmental stressors (including discrimination, sexual 
objectification, childhood trauma, and low social support).  
The vantage sensitivity hypothesis describes traits that confer no difference in risk 
among individuals in higher-risk environments, but are associated with more beneficial 
outcomes in a positive environment (Pluess et al., 2013). For example, high cortisol 
reactivity is conceptualized as a biological indicator of vantage sensitivity; regardless of 
cortisol reactivity, children had similar levels of prosocial behavior when family 
adversity was high, but with a highly supportive family environment, children with high 
cortisol reactivity were more prosocial than children with low cortisol reactivity 
(Auerbach, Bigda-Peyton, Eberhart, Webb, & Ho, 2011; Obradović, Bush, Stamperdahl, 
Adler, & Boyce, 2010). Also, highly sociable adolescents benefit more from online social 
connection compared to adolescents with low sociability (S. J. Lee, 2009). Alexithymia 
moderates the effects of social support on well-being, showing a benefit for people 
without alexithymia and no benefit for those with alexithymia (Kojima, Senda, Nagaya, 
Tokudome, & Furukawa, 2003). Vantage sensitivity to social support is intuitive; 
however, it is unclear whether the same people who are more sensitive to the benefits of 
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social support may also be more sensitive to the detriment of social isolation, or 
discrimination, if a full spectrum of social experiences are examined. 
The differential susceptibility hypothesis was developed to acknowledge 
situations in which individual differences confer increased risk in an adverse environment 
and reduced risk in a positive environment (Pluess & Belsky, 2009). For example, 
children with negative emotional temperaments are more sensitive to both positive and 
negative childcare (Pluess & Belsky, 2009). Evidence that looks like diathesis-stress or 
vantage-sensitivity could be a case of differential susceptibility, if the study failed to 
measure a broad enough range from highly negative to highly positive experience 
(Roisman et al., 2012).  
Current Study 
The current study fills gaps in understanding interconnections between a variety 
of social experiences and social responsiveness traits in depression symptom severity 
using cross-sectional self-report data. We tested which social experiences (perceived 
social support, perceived discrimination, childhood trauma, or sexual objectification) are 
most strongly associated with depression symptom severity and whether the associations 
differ in marginalized groups. We also tested which traits moderate the impact of social 
experiences on depression symptom severity. Interaction effects were investigated in 
context of diathesis-stress, vantage sensitivity, and diathesis stress. We tested a new 
general social responsiveness latent factor underlying shared variance in traits such as 
rejection sensitivity, need to belong, dispositional empathy, self-monitoring, and 
alexithymia. We tested whether this latent variable moderates associations between social 
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experiences and depression symptom severity and investigated interactions in context of 
diathesis-stress, vantage sensitivity, and differential susceptibility. 
Methods 
Undergraduate research participants were recruited from the psychology research 
pool at the University of Nebraska-Lincoln with a brief, vague description of the study, 
stating the purpose as investigating “individual differences, experiences, and mood.” 
Participants received course credit for participation. A total of 1,128 participants 
provided informed consent, completed computerized questionnaires, and were debriefed 
regarding the more detailed purpose of the study. 
Measures 
The Beck Depression Inventory (BDI; Beck, Steer, & Brown, 1996) was used to 
measure depression symptom severity. It is widely used and has high test-retest reliability 
(r = 0.93; Beck, Steer, & Brown, 1996) and high internal consistency (Alpha = 0.91; 
Beck, Steer, Ball, & Ranieri, 1996). Participants responded to 21 multiple choice items 
indicating the intensity of depression symptoms within the past 2 weeks (e.g. response 
options for one item included “I am not particularly discouraged about the future,” “I feel 
discouraged about the future,” “I have nothing to look forward to”, or “I feel the future is 
hopeless and that things cannot improve”). Scores are summed, ranging from 0 to 63, 
with higher scores indicating higher depression symptom severity. Cronbach’s alpha for 
the current sample was .92. 
Perceived social support was measured using the Multidimensional Scale of 
Perceived Social Support (MSPSS; Zimet, Dahlem, Zimet, & Farley, 1988). Participants 
rated 12 items on a scale from 1 (very strongly disagree) to 7 (very strongly agree) 
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regarding relationships with a significant other, family, and friends (e.g. “There is a 
special person with whom I can share my joys and sorrows”). This scale demonstrates 
acceptable internal reliability (Cronbach’s alpha for current sample = .77) and has good 
test-retest reliability (alpha = .85). 
Childhood trauma was measured with the Childhood Trauma Questionnaire 
(Pennebaker & Susman, 2013), which asks participants about six potential traumatic 
experiences prior to age 17, including death of a close friend or family member, upheaval 
between parents, traumatic sexual experience, violence, severe illness or injury, and other 
major upheaval. For each item, participants indicated whether they had experienced it, 
and if yes rated how traumatic it was on a scale of 1 (not at all traumatic) to 7 (extremely 
traumatic). A composite score of the “how traumatic” responses for all items the 
participant experienced yielded the childhood trauma score, with scores ranging from 0 
(reported not experiencing any of the 6 items) to 42 (indicated experiencing all items as 
extremely traumatic). 
Perceived discrimination was measured with the Perceived Discrimination Scale 
(Williams & Mohammed, 2009). This 20-item scale includes 11 items for participants to 
indicate how many times they have experienced discrimination (being treated differently 
from others due to some personal characteristic) during their lifetimes (e.g. “You were 
discouraged by a teacher or advisor from seeking higher education”) and 9 items that ask 
participants to respond on a scale from 1 (often) to 4 (never) regarding general unfair 
treatment (e.g. You are treated with less courtesy than other people”). All items are 
reverse coded and summed to represent scores for perceived discrimination. Cronbach’s 
alpha for the current sample was .85. 
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Sexual objectification was measured using the Interpersonal Sexual 
Objectification Scale (ISOS; Kozee, Tylka, Augustus-Horvath, & Denchik, 2007). 
Participants rated the frequency with which they have experienced 15 items on a scale 
from 1 (never) to 5 (almost always) in the past year. Sample items include: “How often 
have you been whistled at while walking down a street?” and “How often have you been 
touched or fondled against your will?” Mean scores were calculated with higher scores 
representing greater levels of sexual objectification. The ISOS has been structurally 
validated with exploratory and confirmatory factor analysis (Kozee et al., 2007). Previous 
psychometrics report internal consistency of .92 and test-retest reliability of .90. 
Cronbach’s alpha for the current sample was .94. 
The need to belong is the intensity of a person’s desire for acceptance and 
belonging. It is associated with higher risk of depression symptom severity; however, this 
association is buffered by the presence of more fully-satisfying relationships (Pillow, 
Malone, & Hale, 2015). The Need to Belong scale (Leary, Kelly, Cottrell, & 
Schreindorfer, 2013) contains 10 items (e.g. “I try hard not to do things that will make 
other people avoid or reject me”) on which participants indicated their agreement from 0 
(strongly disagree) to 4 (strongly agree). It has acceptable interitem reliability 
(Cronbach’s alpha for the current sample = .75) and test-retest reliability of .87. 
Rejection sensitivity measures likelihood of expecting and being concerned by the 
potential of social rejection and is positively correlated with depression (Gao, Assink, 
Cipriani, & Lin, 2017). It moderates the impact of acute experiences of rejection on self-
concept, which may partially explain the mechanism of its connection with depression 
symptom severity (Ayduk, Gyurak, & Luerssen, 2009). The Rejection Sensitivity 
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Questionnaire (RSQ), examines situations involving potential rejection. The participant 
indicates their concern about a situation’s outcome on a scale from 1 (very unconcerned) 
to 6 (very concerned), and then indicates the likelihood that the other individual would 
respond preferably on a scale from 1 (very unlikely) to 6 (very likely). Scores from 18 
items range from 1 to 36, with higher scores indicating higher rejection sensitivity 
(Downey & Feldman, 1996). An expectancy-value model (Feather, 1988) was used to 
calculate RSQ scores by reverse scoring the expectancy of a positive outcome and 
multiplying it by the score of concern for each item, then calculating an average across 
items. Cronbach’s alpha for the current sample was .91. 
Alexithymia is a stable, continuous trait representing difficulty identifying, 
processing, and verbalizing emotions in oneself and others (Martínez-Sánchez, Ato-
García, & Ortiz-Soria, 2003). Higher alexithymia is associated with depression and 
anxiety (Marchesi, Brusamonti, & Maggini, 2000); however, this trait also interacts with 
experience in association with depression symptom severity. In Japanese workers, the 
association between social support and lower depression severity was only present for 
low alexithymia individuals (Kojima et al., 2003). Alexithymia was assessed using the 
Online Alexithymia Questionnaire-G2 (OAQ-G2). This scale includes 37 items rated on a 
scale of 1 (strongly disagree) to 5 (strongly agree), with higher scores indicating more 
alexithymia (J. Thompson, 2007). Cronbach’s alpha for the current sample was .88. 
Dispositional empathy is one’s tendency to share in the emotions of others. Lower 
empathy is associated with higher depression symptom severity via unforgiving 
temperament (Burnette, Davis, Green, Worthington Jr, & Bradfield, 2009). Although 
lower empathy is typically associated with higher depression symptom severity, (Bennik, 
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Jeronimus, & Aan Het Rot, 2019), high empathy can also be a risk factor for depression 
for people with certain traits, including poor emotion regulation (Tully, Ames, Garcia, & 
Donohue, 2016). Dispositional empathy was assessed with the Interpersonal Reactivity 
Index (Carey, Fox, & Spraggins, 1988). This measure includes 28 items which 
participants rate from 1 (“Does not describe me well”) to 5 (“Describes me very well”). 
Scores on items (e.g. “I often have tender, concerned feelings for people less fortunate 
than me”) are aggregated. Internal consistency is adequate with Cronbach’s alpha of .85 
for the current sample. Test-retest reliability is also adequate, ranging from .61-.81 (M. 
H. Davis, 1980).  
Self-monitoring is a person’s tendency to closely attend to the social environment 
and modulate their behavior based on that context. People high in self-monitoring have 
lower autonomic and cortical arousal in anticipation of social threat compared to people 
with low self-monitoring (Hofmann, 2006). Although self-monitoring is usually 
associated with higher social abilities that may be protective against depression, and self-
monitoring techniques focused on positive experiences can be used to reduce depression 
symptom severity (Kauer et al., 2012), higher self-monitoring is also associated with 
some risk. Higher self-monitoring is associated with substance use, which can also be 
associated with depression, and when impression management attempts are perceived as 
unsuccessful, the self-monitoring process can lead to higher anxiety and lower self-
esteem (Sharp & Getz, 1996). Self-monitoring was measured with the Self-Monitoring 
Scale (SMS; Snyder, 1974) which includes 25 items (e.g. “When I am uncertain how to 
act in a social situation, I look to the behavior of others for cues”) to which participants 
respond true or false. A sum score of number of items answered with the “high self-
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monitoring” response option was calculated. Cronbach’s alpha for the current sample was 
.72. 
Data Analytic Methods 
 Statistical analyses were conducted with MPlus software (Muthén & Muthén, 
2010) using maximum likelihood estimation with robust standard errors (MLR) to 
account for any non-normality. A model-building approach was used to provide clear 
understanding of the value of including more contextual factors in the investigation of 
depression symptom severity. To reduce risk of false positives due to multiple testing, a 
Bonferroni correction was used to control the familywise error rate for the 41 estimates 
used to test hypotheses. The corrected p value of .001 was used as the threshold for 
significance in all analyses. 
A multiple regression including social support, childhood trauma, perceived 
discrimination, and sexual objectification in association with depression symptom 
severity was implemented to identify which experiences are uniquely associated with 
depression symptom severity (see Figure 2.1). Gender, status as a racial minority, status 
as a sexual minority, and status as a Latinx person were included as covariates. Gender 
identity was reported as man or woman, and separate reporting of sex (male or female) 
indicated <0.2% transgender identities, so transgender identities were not separated for 
analysis. For full data on sexual orientation and racial diversity, see Table 2.1. 





Figure 2.1. Multiple regression of social experiences on depression symptom 
severity. Perceived social support, childhood trauma, perceived discrimination, and 
sexual objectification were included as predictors of depression symptom severity in the 
regression model. Gender, status as a racial minority, status as a sexual minority, and 
status as a Latinx person were included as covariates. Covariances among all exogenous 





Table 2.1: Univariate Statistics 
Gender (N = 1,123) Man n = 316 (28.10%) 
Woman n = 807 (71.54%) 
Sexual Orientation (N = 1,128) Straight n = 1014 (89.89%) 
Gay/Lesbian n = 24 (2.13%) 
Bisexual n = 67 (5.94%) 
Pansexual n = 15 (1.33%) 
Asexual n = 4 (0.35%) 
Other n = 4 (0.35%) 
Race (N = 1,095) White n = 877 (77.75%) 
Black n = 55 (4.88%) 
Chinese n = 44 (3.90%) 
Vietnamese n = 33 (2.93%) 
Japanese n = 1 (0.09%) 
Asian Indian n = 15 (1.33%) 
Other Asian racial identity n = 23 (2.04%) 
Native American n = 9 (0.80%) 
Pacific Islander n = 3 (0.37%) 
Race not captured by 
survey options 
n = 35 (3.10%) 
Hispanic/ Latinx (N = 1,124) Hispanic n = 100 (8.87%) 
Not Hispanic n = 1024 (90.78%) 
Age (N = 1,122) M = 20.34, SD = 2.60 
Need to Belong (N = 1,125) M = 34.51, SD = 5.99 
Rejection Sensitivity (N = 1,128) M = 7.19, SD = 2.96 
Self-monitoring (N = 1,128) M = 12.69, SD = 3.80 
Alexithymia (N = 1,093) M = 95.26, SD = 16.44 
Dispositional Empathy (N = 1,128) M = 3.11, SD = 0.31 
Perceived Social Support (N = 1,128) M = 5.43, SD = 0.88 
Perceived Discrimination (N = 1,109) M = 12.16, SD = 7.77 
Sexual Objectification (N = 1,128) M = 1.93, SD = 0.68 
Childhood Trauma (N = 1,128) M = 6.99, SD = 6.21 
Depression Symptom Severity (N = 
1,123) 
M = 9.65, SD = 8.73 
 
To investigate how the model may differ based on marginalized group identity, 
multiple group analyses were conducted. The regression model was compared between 
men and women, between White participants and people with a racial minority identity, 
and heterosexual people compared to people with a sexual minority identity. 
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Several moderation models tested whether self-monitoring, rejection sensitivity, 
dispositional empathy, alexithymia, and need to belong moderate associations between 
social experiences and depression symptom severity. The possible moderating roles of 
each social responsiveness trait on associations between depression symptom severity 
and each social experience are shown in Figure 2.2. For conceptual simplicity, only one 
social responsiveness trait was included in the model at a time. Each model also included 
gender, status as a racial minority, status as a sexual minority, and status as a Latinx 
person as covariates. Covariance among all exogenous variables were included in the 
model. 
Figure 2.2. Interactions between social experiences and social responsiveness traits 
in association with depression symptom severity. Separate models were run for each 
potential moderator. Gender, status as a racial minority, status as a sexual minority, and 
status as a Latinx person were included as covariates. Covariance among all exogenous 

























Discrimination Depression symptoms 
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Significant interaction effects were subsequently examined in context of 
diathesis-stress, vantage sensitivity, and differential susceptibility (Roisman et al., 2012). 
All significant interactions were probed for the range of significance using the LOOP 
command to determine a) for what range of the social responsiveness trait is the 
association between the social experience and depression symptom severity significant? 
and b) for what range of the social experience is the association between the social 
responsiveness trait and depression symptom severity significant? To support differential 
susceptibility, there must be a true cross-over interaction and the regions of significance 
test must reveal regions within the possible range of social experience scores with both a 
significant positive and negative association between the trait and depression symptom 
severity. This test must be robust to family-wise error correction and test for a non-linear 
effect, to support the differential-susceptibility hypothesis (Roisman et al., 2012). Testing 
this hypothesis with a variety of social experiences and social responsiveness traits yields 
information about specificity. 
A confirmatory factor analysis was used to determine whether using rejection 
sensitivity, need to belong, dispositional empathy, self-monitoring, and alexithymia as 
indicators of a latent variable of Social Responsiveness is justifiable. Global model fit 
was assessed with Comparative Fit Index (CFI > .90 indicates adequate fit; Bentler, 
1990), Tucker-Lewis Index (TLI > .90 indicates adequate fit; Tucker & Lewis, 1973), 
Root Mean Square Error of Approximation (RMSEA > .10 indicates poor fit; Browne & 
Cudeck, 1992), and the Standard Root Mean Residual (SRMR > .10 indicates poor fit; 
MacCallum, Browne, & Sugawara, 1996) prior to interpretation of path coefficients. 
Factor loadings were investigated, using a threshold of .3 or higher for retaining 
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indicators. This latent variable was tested as a moderator between social experiences and 
depression symptom severity (See Figure 2.3). The same procedure for testing 
differential susceptibility was used for the latent variable interaction and the observed 
variable moderation effects. 
 
Figure 2.3: Theoretical model of Social Responsiveness latent variable moderating 
associations between social experiences and depression symptom severity. Gender, 
status as a racial minority, status as a sexual minority, and status as a Latinx person were 
included as covariates. Covariance among all exogenous variables were included in the 
model. 
 
 Because tests of differential susceptibility often fail due to restricted range of 
environmental context, this study also tests whether any of the potential moderators 
interact with an aggregate score of social experiences in association with depression 
symptom severity. The net social experiences score was calculated by creating an 
aggregate of Z scores of perceived social support, childhood trauma, perceived 




Univariate statistics are shown in Table 2.1. These descriptive statistics align with 
those expected of a midwestern United States college student sample (Luster-Edward & 
Martin, 2019). Demographics are representative of the university where the sample was 
obtained (Data Index). Continuous variables were relatively normally distributed, and 
robust maximum likelihood estimation (MLR) was used for analyses to avoid bias due to 
univariate and multivariate non-normality in hypothesis testing. Bivariate correlations are 
shown in Table 2.2. None of the correlations exceeded r = .7, so no variables were 




Table 2.2: Bivariate Correlations 
 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 
1. Gender 1 
             
2. Age 0.10* 1 
            
3. Sexual 
orientation  
0.00 0.01 1 
           
4. Hispanic  -0.01 -0.01 0.04 1 
          
5. Racial 
minority 
0.05 0.08 0.02 0.10* 1 
         
6. Need to 
belong 
-0.19* -0.15* 0.01 -0.07 -0.16* 1 
        
7. Rejection 
sensitivity 
-0.01 -0.04 0.20* 0.08 0.02 0.22* 1 
       
8. Self-
monitoring 
0.12* -0.02 0.00 -0.02 0.03 0.21* 0.07 1 
      
9. Alexithymia 0.15* 0.00 0.03 0.04 0.18* -0.01 0.31* -0.01 1 
     
10. Empathy -0.09 -0.03 0.11* -0.04 -0.03 0.23* 0.18* 0.16* 0.06 1 
    
11. Perceived 
social support 
-0.12* -0.03 -0.10* -0.09 -0.11* 0.11* -0.32* -0.03 -0.27* -0.02 1 
   
12. Childhood 
trauma 












-0.08 -0.02 0.22* 0.05 0.07 0.20* 0.47* 0.12* 0.35* 0.22* -0.30* 0.27* 0.44* 0.22* 
* = significant at the p < .001 level. The following variables are coded as bivariate: Gender (woman = 0, man = 1), sexual orientation 
(0= heterosexual, 1 = sexual minority), Hispanic (0 = not Hispanic, 1 = Hispanic), race (0 = White, 1 = racial minority). 
 
 The multiple regression model was just identified, so global fit was perfect. There 
was no more than 2% missing data for any combination of variables. Perceived social 
support, childhood trauma, and perceived discrimination were all uniquely associated 
with depression symptom severity (p < .001 for all regression coefficients), but sexual 
objectification was not (p = .36). Comparing the standardized regression coefficients, 
perceived discrimination (B = .35) followed by perceived social support (B = -.21) were 
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the strongest predictors of depression symptom severity, and childhood trauma as well as 
some of the demographic variables had smaller contributions to the model (childhood 
trauma B = .13, gender B = -.11, sexual orientation B = .15). See Figure 2.4. 
Figure 2.4: Regression Demonstrating Relative Contribution of Social Experiences 
to Depression Symptom Severity. Gender, age, race, sexual orientation, and ethnicity 
were included as covariates. 
 
 Multiple group analysis allowed comparison of unstandardized regression 
coefficients to provide preliminary evidence regarding how the model differs across 
demographic groups. Comparisons are shown in Table 2.3. The sample of women (n = 
807) was larger and had higher depression levels than the sample of men (n = 316). 
When comparing the model for women compared to men, childhood trauma was only 
significantly associated with depression symptom severity for women (b = .17, p = .002), 
but not for men (b = .18, p = .06). Considering the larger regression coefficient but not 
statistically significant p value for men, the lack of power to detect statistical significance 
in men that was found in women is likely an issue of sample size. Sexual orientation 
contributed more to depression symptom severity for women (b = 5.16) than for men (b 
= 3.86), but the smaller sample of sexual minority men may have made this estimate 
unreliable. Perceived social support contributed more to depression symptom severity for 
men (b = -2.35) than for women (b = -1.96). Perceived discrimination contributed 
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equally to depression symptom severity for men (b = .39) and women (b = .40). The 
model explained an equal amount (30%) of the variance in depression symptom severity 
in men and women (R2 = .30). 
Table 2.3: Multiple Group Analysis 


















n = 807 
b = .17, p = .002 b = -1.96, p < .001 b = .40, p < .001 
Men 
n = 316 
b = .18, p = .06 b = -2.35, p < .001 b = .39, p < .001 
Race Racial minority 
n = 183 
b = .13 p = .27 b = -1.59, p = .018 b = .38, p < .001 
White 
n = 877 




minority n = 
109 
b = .22, p = .131 b = -3.13, p = .002 b = .45, p = .001 
Heterosexual 
n = 1014 
b = .16, p = .001 b = -1.85, p < .001 b = .38, p < .001 
* Separate gender and sex reporting indicated <0.2 % transgender identities, so these 
identities were not separated from cis men and cis women. 
 
 When comparing people who identified as White (n = 877) compared to people 
who identified as a racial minority (n = 218), the association between childhood trauma 
and depression appeared to be only significant for participants who identified as White (b 
= .17, p = .001) compared to racial minority participants (b = .13 p = .27), but this 
difference may be partially due to the decreased statistical power in the racial minority 
group. Sexual orientation was also only associated with depression symptom severity in 
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the model for White participants, and although sample size may partially explain the lack 
of significance in the racial minority group, the magnitude of the regression coefficient 
was also substantially larger for White participants (b = 5.28, p < .001) compared to 
racial minority participants (b = 1.82, p = .33). Perceived social support contributed more 
to the model for White participants (b = -2.12, p < .001) compared to racial minority 
participants (b = -1.59, p = .018), and gender contributed more for racial minority 
participants (b = -1.86, p = .003) than White participants (b = -2.85, p = .016). Perceived 
discrimination contributed equally for White participants (b = .39, p < .001) and racial 
minority participants (b = .38, p < .001).  
 Possibly due to the small sample size of participants identifying as a sexual 
minority (n = 90), contributions of perceived social support (b = -3.13 p = .002), 
childhood trauma (b = .22, p = .13), and gender (b = -3.90, p = .04) were not statistically 
significant (at least when correcting for multiple testing). All these effect sizes appeared 
larger than those for heterosexual participants (perceived social support b = -1.85, p < 
.001; childhood trauma b = .16, p = .001; gender b = -2.00, p < .001), although statistical 
significance was only present in the larger heterosexual group. Contribution of perceived 
discrimination to variation in depression symptom severity was also higher in sexual 
minority participants (b = .45, p = .001) compared to heterosexual participants (b = .38, 
p < .001). Identifying as Hispanic did not contribute to any of the models, except for in 
sexual minorities (b = -5.84, p = .004), indicating that sexual minorities who are also 
Latinx had lower levels of depression compared to sexual minorities who were not 
Latinx. This effect did not remain significant after Bonferroni correction. The amount of 
variance in depression symptom severity accounted for by this model appeared 
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substantially larger for sexual minority participants (R2 = .42) than heterosexual 
participants (R2 = .25). 
Need to belong did not moderate any of the paths from perceived social support (b 
= -0.05, p = .31), childhood trauma (b = 0.01, p = .11), perceived discrimination (b = 
0.001, p = .89), or sexual objectification (b = 0.09, p = .19) to depression symptom 
severity. In this model, the main effects of dispositional empathy (b = 1.54, p = .06) and 
self-monitoring (b = .08, p = .17) were also not statistically significant. The main effect 
of need to belong on depression symptom severity was significant (b = .16, p < .001), 
with higher scores of need to belong conferring higher risk of depression symptom 
severity. 
Rejection sensitivity moderated the association between social support and 
depression symptom severity (b = -0.32, p < .001). This suggests that the negative 
correlation between social support and depression in the model is stronger for people 
with higher rejection sensitivity. Inspection of the regions of significance indicated that 
for values of perceived social support lower than 6.15 (a value .82 of one standard 
deviation above the mean), rejection sensitivity was positively associated with depression 
symptom severity; however, for higher values of social support rejection sensitivity was 
not associated with depression symptom severity. For rejection sensitivity scores above 
3.13 (a value 1.37 standard deviations below the mean), social support was negatively 
associated with depression symptom severity. Rejection sensitivity did not moderate the 
paths from childhood trauma (b = .01, p = .44), perceived discrimination (b = .02, p = 
.23), or sexual objectification (b = 0.15, p = .21) to depression symptom severity. In this 
model, the main effects of dispositional empathy (b = 1.83, p = .03) and self-monitoring 
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(b = .09, p = .11) were also not statistically significant. The main effect of rejection 
sensitivity at average levels of social support was significant (b = 0.46, p < .001), with 
higher levels of rejection sensitivity conferring higher risk of depression symptom 
severity. 
 Self-monitoring did not moderate any of the paths from perceived social support 
(b = 0.10, p = .12), childhood trauma (b = -0.003, p = .78), perceived discrimination (b 
= 0.01, p = .64), or sexual objectification (b = 0.15, p = .17) to depression symptom 
severity. Self-monitoring also had no main effect on depression symptom severity (b = 
0.08, p = .15). 
 Dispositional empathy did not moderate any of the paths from perceived social 
support (b = -0.65, p = .69), childhood trauma (b = 0.01, p = .96), perceived 
discrimination (b = -0.06, p = .73), or sexual objectification (b = 2.06, p = .23) to 
depression symptom severity. The main effect of dispositional empathy was also non-
significant after family-wise error correction (b = 1.72, p = .04). 
 Alexithymia moderated the association between social support and depression 
symptom severity (b = -0.05, p = .004), revealing a stronger negative correlation between 
social support and depression for people with higher alexithymia. Inspection of the 
regions of significance indicated that when social support is below 6.54 (a value 1.26 
standard deviations above the mean) higher alexithymia was associated with higher 
depression symptom severity and only for values of alexithymia above 68.55 (a value 
1.64 standard deviations below the mean), social support was negatively associated with 
depression symptom severity. Alexithymia did not moderate the paths from childhood 
trauma (b = .004, p = .08), perceived discrimination (b = .004, p = .11), or sexual 
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objectification (b = 0.002, p = .93) to depression symptom severity. The main effect of 
alexithymia at average levels of perceived social support was significant (b = .10, p < 
.001), with higher scores of alexithymia conferring higher depression symptom severity. 
 A confirmatory factor analysis evidenced an underlying factor connecting need to 
belong, rejection sensitivity, self-monitoring, and dispositional empathy. Because 
alexithymia had no statistically significant bivariate correlation with need to belong, 
dispositional empathy, or self-monitoring, it was not included. The global fit was 
adequate, as indicated by CFI = .98, TLI = .93, RMSEA = 0.04, 90% CI [0.01, 0.52], 
SRMR = 0.02. The standardized coefficients for all indicators were significant and 
sufficiently large (rejection sensitivity B = .36, p < .001; need to belong, B = .58, p < 
.001; dispositional empathy, B = .43, p < .001; self-monitoring, B = .34, p < .001). 
Rejection sensitivity was the scaling indicator.  
Social Responsiveness moderated the association between perceived social 
support and depression symptom severity (b = -0.73, p = .01). The negative correlation 
between perceived social support and depression symptom severity was stronger for 
people with higher Social Responsiveness. Social Responsiveness also moderated the 
association between depression symptom severity and perceived discrimination (b = 
0.16, p = .003). The positive correlation between perceived discrimination and 
depression symptom severity was stronger for people with higher Social Responsiveness. 
The region of significance test revealed that Social Responsiveness was positively 
associated with depression symptom severity for all meaningful values of perceived 
social support. For people with Social Responsiveness above 10.82 (a value a little below 
the mean), higher perceived social support predicted lower depression symptom severity. 
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For all values of Social Responsiveness, higher perceived discrimination was associated 
with higher depression symptom severity, but the association was stronger for higher 
values of Social Responsiveness. Higher Social Responsiveness was associated with 
higher depression symptom severity for values of perceived discrimination above 11.38 
(a value just below the average) and higher Social Responsiveness was associated with 
lower depression symptom severity for values of perceived discrimination below 8.79 (a 
value .43 of a standard deviation below the mean). 
After aggregating the Z scores of all social experience variables (social support, 
discrimination, childhood trauma, and sexual objectification), reverse scoring the 
negative social experiences (all except social support), the net social experience score 
ranged from -11.42 to 5.65, with higher scores indicating more net positive social 
experiences. This score was negatively associated with depression symptom severity in 
bivariate (r = -.49, p < .001) and multivariate (b = -1.14, p < .001) contexts.  
 The association between net social experiences and depression symptom severity 
was moderated by rejection sensitivity (b = -0.08, p = .01), need to belong (b = -0.03, p 
= .008), and alexithymia (b = -0.02, p < .001); however, only the moderation by 
alexithymia remained significant after Bonferroni correction. For all three traits, the 
association between social experience and depression was stronger for people higher in 
the social responsiveness trait. The association between social experience and depression 
symptom severity was not moderated by dispositional empathy (b = 0 .21, p = .46) or 
self-monitoring (b = -0.003, p = .90), which also had no main effects in this model. The 
association between net social experiences and depression symptom severity was also 
moderated by the latent variable of Social Responsiveness, b = -0.36, p < .001.  
34 
 
Regions of significance tests revealed that for all meaningful values of rejection 
sensitivity, more positive net social experience was associated with lower depression 
symptom severity. Higher rejection sensitivity was associated with higher depression 
symptom severity at net social experience values below 3.76. Higher need to belong was 
only associated with higher depression symptom severity for net social experience scores 
below 2.52. More positive net social experiences were only associated with lower 
depression symptom severity for people with need to belong scores higher than 14.84. 
Higher alexithymia was only associated with higher depression symptom severity for net 
social experience scores below 3.35. More positive net social experiences were only 
associated with lower depression symptom severity for alexithymia scores above 60.47. 
For all values of net social experience below 5.62, higher Social Responsiveness was 
associated with higher depression symptom severity. For values of Social Responsiveness 
above 6.72, more positive net social experience was associated with lower depression 
symptom severity. 
Discussion 
We found that perceived social support and perceived discrimination contribute 
more to variation in depression symptoms than childhood trauma or sexual objectification 
and that these associations are moderated by individual differences in social 
responsiveness traits.  Our findings extend the literature by including social support, 
childhood trauma, perceived discrimination, and sexual objectification in the same model 
to show relative unique contributions of each variable in depression symptom severity, so 
this novel analysis yielded information about which social experiences on average 
contribute the most to symptoms of depression in college students. Furthermore, this 
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study investigated the specific nature of interactions between social experiences and 
traits, revealing that some experiences are only associated with depression symptom 
severity for people with certain traits, and likewise, some traits are only risk factors in the 
context of environmental risk. For each question addressed by this study, there are both 
useful implications and limitations. 
Perceived social support, perceived discrimination, and childhood trauma all have 
unique contributions to variance in depression symptom severity, when controlling for 
race, ethnicity, gender, and sexual orientation. We found that perceived discrimination (B 
= .35) followed by perceived social support (B = -.21) were the strongest predictors of 
depression symptom severity, so focusing on perceptions of these experiences in 
therapeutic settings may be particularly important for depression treatment. Sexual 
objectification not contributing to the model may be because of its associations with 
perceived discrimination and gender; sexual objectification is not uniquely associated 
with depression symptom severity when controlling for these other closely related 
variables. The ranked order of importance of these social experiences did not vary by 
gender, race, or sexual orientation. However, the strength of the effect sizes did have 
apparent differences prima facie for some group analyses, although smaller sample size 
for minority status groups means caution is recommended in interpreting these results, 
and nested group comparisons would be necessary to test significance of differences in 
the model across groups.  
Sexual orientation and perceived social support contributed more to variation in 
depression symptom severity for people who identified as White compared to those who 
identified as a racial minority; however, this is likely due to a small sample size of sexual 
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minorities.  It is also possible that the stress of being a sexual minority or having low 
social support is more noticeable for White people who otherwise have privilege relative 
to racial minorities, or because of the learned resilience from membership of multiple 
marginalized identities. This is consistent with evidence that women veterans who were 
both racial/ethnic and sexual minorities had lower risk, despite membership of one or the 
other type of minority being associated with higher risk (Lehavot et al., 2014). Perceived 
social support and perceived discrimination both had larger effect sizes in the model for 
sexual minorities relative to people who identified as heterosexual, perhaps suggesting 
that this vulnerable identity may increase the weight of social support and discrimination 
in variation in depression symptom severity. It is possible that because racial minority 
identities are generally more visible than sexual minorities identities, racial minority 
members have more constant stress resulting from their identities that might wash out 
some of the variance resulting from other social experiences. For people who identify as 
a sexual minority, however, variation in depression symptom severity is especially highly 
associated with whether they feel they are receiving a lot of support or are targeted by a 
lot of discrimination. The amplification of the impact of perceived social support and 
discrimination in sexual minorities is consistent with evidence that social support may 
reduce depression symptoms via reduced stigma and desire to conceal sexual orientation 
(Ding et al., 2020). 
The association between perceived social support and depression symptom 
severity was variable based on individual differences in social responsiveness traits. The 
association between higher perceived social support and lower depression symptom 
severity was only present for people with rejection sensitivity scores above 3.13 (a value 
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1.37 standard deviations below the mean) or alexithymia above 68.55 (a value 1.64 
standard deviations below the mean). Other interaction effects with observed variables 
were non-significant. Higher scores of rejection sensitivity and alexithymia were 
associated with higher risk of depression symptom severity, but only in an adverse 
environment (low social support), which is consistent with diathesis-stress. 
The moderation of the association between perceived social support and 
depression symptom severity by alexithymia suggests that although people with high 
alexithymia may not understand emotions well, feeling like they are supported by people 
around them is particularly important for them, and when that support is absent, they are 
at increased risk of depression relative to those with low alexithymia. Because there is no 
level of social support at which alexithymia is indicative of reduced risk of depression, 
this appears to be a case of diathesis-stress and not differential susceptibility.  
The utility of the Social Responsiveness latent variable supports the idea that 
there is some underlying factor explaining part of the shared variance in rejection 
sensitivity, dispositional empathy, self-monitoring, and need to belong. This latent 
variable had good global and local fit and moderated effects of perceived social support 
and perceived discrimination on depression symptom severity. Rejection sensitivity, need 
to belong, self-monitoring, and dispositional empathy, but not alexithymia may share an 
underlying cause. 
Social Responsiveness moderated associations from both perceived social support 
and perceived discrimination to depression symptom severity. Higher Social 
Responsiveness yielded stronger associations between both perceived social support and 
perceived discrimination with depression symptom severity. Social Responsiveness was 
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associated with higher depression symptom severity for participants with perceived 
discrimination scores above 11.38 (a value just below the average) and higher Social 
Responsiveness was associated with lower depression symptom severity for values of 
perceived discrimination below 8.79 (a value .43 of a standard deviation below the 
mean). Higher perceived discrimination was associated with higher depression symptom 
severity at all levels of Social Responsiveness, but the association was stronger at higher 
levels of Social Responsiveness. Thus, higher Social Responsiveness does amplify the 
protective effect of perceived social support and risk of perceived discrimination on 
depression symptom severity. Furthermore, because there is a true cross-over interaction 
where Social Responsiveness is associated with elevated depression symptoms in an 
adverse environment (high levels of perceived discrimination) and lower depression 
symptom severity in a positive environment (low levels of perceived discrimination), this 
is consistent with the potential of differential susceptibility. 
Although using an aggregate score of net social experiences to capture a range 
from highly negative to highly positive overall social experiences did not increase the 
ability to detect instances of differential susceptibility, it was moderated by several of the 
social responsiveness traits. The effect of net social experiences on depression symptom 
severity was moderated by rejection sensitivity, need to belong, and alexithymia, and the 
moderation of alexithymia survived Bonferroni correction. It appears that there is some 
specificity in social responsiveness interactions with social experiences, but there is also 
utility in using a net social experience measure and Social Responsiveness latent variable 
to detect overall effects. 
Strengths, Limitations, and Future Directions 
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This study used well-validated measures to assess a good variety of social 
experiences and social responsiveness and the most used dimensional measure of 
depression symptoms. Including both positive and negative social experiences allows this 
study to provide information about the specificity and nature of moderating effects that 
many studies cannot (Roisman et al., 2012). This is the first known study to assess a 
latent variable of Social Responsiveness that helps inform what components of this trait 
may not be captured by existing measures of social responsiveness, which are often used 
to assess traits related to autism spectrum disorder (Hus, Bishop, Gotham, Huerta, & 
Lord, 2013). Additionally, this study was strongly powered with a sample of 1,128 
participants, so it was able to reliably test complex statistical associations. 
This study only included four social experiences, and inclusion of other known 
factors in depression symptom severity (e.g. genetics, socioeconomic status) could 
provide useful information about the importance of these social experiences relative to 
other factors (Rush, 2007). Furthermore, a more diverse sample would allow for more 
effective investigations of how contribution to depression risk differs in marginalized 
groups and why. 
The multiple group analyses are limited by the diversity of the sample and future 
research should focus more on people with minority identities. Even when the analyses 
compared all participants with some racial minority status to White participants, the 
racial minority group was substantially smaller. The same was true for the sexual 
minority group. It is also important to note that although the current sample did not 
include enough participants of each racial or sexual orientation identity to test each group 
separately, it is very possible that the model would look different across these groups. 
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Although there are some relevant experiences in common among people who identify as 
a racial minority (particularly with regards to a social stress model), this study’s inability 
to look at the experiences of Black Americans separately from Indigenous Americans, 
Asian Americans, or international students, for example is a notable limitation and future 
work should focus on these groups (Bostwick et al., 2014). 
The association between childhood trauma and depression appeared to be only 
statistically significant for White and not racial minority participants, but this difference 
may be partially due to the increased statistical power for testing the model in White 
participants. Sexual orientation was also only statistically-significantly associated with 
depression symptom severity in the model for White participants, and although sample 
size may partially explain the lack of significance in the racial minority group, the 
magnitude of the regression coefficient was also substantially larger for White 
participants compared to racial minority participants. Identifying as Hispanic did not 
yield statistically significant effects in the models, likely due to the small sample of 
Latinx participants. The significantly lower levels depression in sexual minority Latinx 
participants compared to heterosexual Latinx participants might also be driven by the 
small number of Latinx participants and even smaller number of Latinx participants who 
were also sexual minorities. 
The existence of a general Social Responsiveness factor aligns with theories of 
resilience and differential susceptibility, but a full understanding of this factor requires 
further investigation. Researchers should investigate what other traits (such as emotional 
intelligence or social perceptual acuity) relate to Social Responsiveness and which are 
distinct (like alexithymia was in the current study). If the underlying factor also explains 
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substantial shared variance for responsiveness traits that are not specifically social in 
nature (e.g. affect lability, sensory processing sensitivity, or startle reflex), and if it is 
found that this factor moderates the effects of non-social experiences (e.g. injury, illness, 
financial stress) as well, that would reshape our understanding of this trait, reflecting that 
it is not in fact specific to social context. Similarly, investigating biological systems 
associated with Social Responsiveness could explain underlying mechanisms for these 
individual differences. If this factor is specific to social experiences, it may be connected 
to biological systems such as the oxytocin system that has implications in a lot of social 
behavior (Heinrichs, Baumgartner, Kirschbaum, & Ehlert, 2003; Kirsch, 2015; Norman 
et al., 2012). 
Although a spectrum of depression symptom severity is more useful than a 
categorical outcome, a more multidimensional approach assessing different types of 
depression symptoms would specify which symptoms are associated with which risk 
factors.  The BDI is intended as a single factor, but a different assessment tool, like the 
Inventory of Depression and Anxiety Symptoms, would help isolate separate symptom 
dimensions including Suicidality, Lassitude, Insomnia, Appetite Loss, Appetite Gain, Ill 
Temper, Well-Being, Panic, Social Anxiety, and Traumatic Intrusions (Watson et al., 
2007). 
The current study provided useful information about which social experiences 
contribute most to depression symptom severity, but more research is required to 
determine the utility of interventions focused on coping with discrimination or nurturing 
social support. We demonstrated that individual differences in rejection sensitivity, 
alexithymia, and general Social Responsiveness moderate these associations. However, 
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further understanding of biological factors underlying some individual differences may 
help researchers and clinicians understand individual depression risk and treatment 
options. For example, if certain biological systems such as the serotonin system or 
oxytocin system are primarily associated with depression symptom severity via an 
association with individual differences in certain social responsiveness traits, 
pharmaceuticals targeting these systems may only be helpful in certain social 
environmental contexts.  
This study reiterates the importance of social experiences, particularly perceived 
social support and discrimination, in association with depression symptom severity, 
across race, gender, and sexual orientation. It also demonstrates a moderating role of 
rejection sensitivity, alexithymia, and Social Responsiveness, and shows the utility of 
considering shared variance in social responsiveness traits such as rejection sensitivity, 




CHAPTER 3: ASSOCIATIONS BETWEEN GENETIC VARIATION IN THE HUMAN 
OXYTOCIN SYSTEM AND DEPRESSION: A SYSTEMATIC REVIEW 
Abstract 
Because of its prevalence, potential lethality, and heritability, depression is a 
common focus of behavior genetics research. The oxytocin system has received 
increasing attention as a candidate biological system in the etiology of depressive 
symptomology. This review satisfies the need for a summary of evidence regarding 
oxytocin-related genetic variation associated with depression symptoms. This systematic 
review followed Preferred Reporting Items for Systematic Reviews and Meta-Analyses 
(PRISMA; Moher, Liberati, Tetzlaff, & Altman, 2009) guidelines. The authors searched 
PubMed and PsychInfo for search terms “Oxytocin AND Depression AND Genetics.” 
After exclusion of studies that did not include a measure of human genomic variance and 
a measure of depression or depression symptoms, 34 studies were reviewed. Results 
summarize variants in the studies and weigh methodological trade-offs across studies. 
Assessing the cumulative behavior genetics evidence in this area is crucial considering 
small effect sizes and replication failure in candidate gene association studies. Identifying 
the variants that have evidence from multiple studies and/or strong evidence will guide 
future studies in selecting polymorphisms for an oxytocin system cumulative genetic risk 
score of depression symptoms. 
Associations between genetic variation in the human oxytocin system and 
depression: A systematic review 
Depression impacts more than 300 million people worldwide (Steel et al., 2014) 
and is associated with high mortality and morbidity. Despite some variation in depression 
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rates across socioeconomic status, gender identities, and countries, depression diagnoses 
are ubiquitous across populations (Bhuiyan, Kabir, Payton, & Mitra, 2019). Although 
almost twice as many women are diagnosed with depression compared to men (Salk, 
Hyde, & Abramson, 2017), this diagnosis is common in men as well, and no groups are 
exempt from depression risk. 
Depression increases risk of mortality by suicide, cardiovascular disease (Barth, 
Schumacher, & Herrmann-Lingen, 2004), stroke (Gump, Matthews, Eberly, & Chang, 
2005), and accidents (Laursen, Musliner, Benros, Vestergaard, & Munk-Olsen, 2016). 
People with depression have more than 20 times increased risk of death due to suicide 
compared to healthy controls (Osby, Brandt, Correia, Ekbom, & Sparen, 2001). 
Associations between depression and death from cardiovascular disease and stroke are 
partially explained by stress-related chronic inflammation, but may also be partially 
attributed to stress and lower mood resulting from cardiovascular events and health 
factors that contribute to both depression and cardiovascular health (Chauvet-Gelinier & 
Bonin, 2017). 
The severity of depressive symptoms is associated with progressively worse 
psychosocial disability (Judd et al., 2000), effecting people’s ability to work and care for 
themselves and their relationships. Depression is associated with absenteeism and 
decreased workplace productivity (Evans-Lacko & Knapp, 2016). People with depression 
often suffer social and cognitive dysfunction (Hodgetts, Gallagher, Stow, Ferrier, & 
O'Brien, 2017; Knight & Baune, 2018). In addition to the quality of life issues inherent to 
a diagnosis of depression, symptoms of depression can lead to difficulties with social 
relationships and work that can further exacerbate symptoms with cycles of self-blame 
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and social withdrawal (Zimmer-Gembeck, Nesdale, Webb, Khatibi, & Downey, 2016). 
Depression can often be chronic and resistant to treatment efforts (Chae et al., 2019). 
Risk factors vary widely, from genetics and prenatal environment to cognitive 
tendencies and life events (Rush, 2007). Adverse life experiences are associated with 
depression, particularly in high stress environments with low social support (Von 
Cheong, Sinnott, Dahly, & Kearney, 2017). The experiences and genetically-based risk 
factors associated with depression are not independent, and genetic-based biological risk 
factors are often considered in context of how they may increase responsiveness to 
environmental stressors, as described by the diathesis-stress hypothesis (Rende & Plomin, 
1992). The strongest risk factors for depression vary across age groups but generally 
include socio-economic status, life stressors, personality factors, social circumstances, 
and physical health (Schaakxs et al., 2017). Differences in biological systems associated 
with depression can develop early on due to prenatal environment and genetics (Abbott, 
Gumusoglu, Bittle, Beversdorf, & Stevens, 2018). 
The Oxytocin System and Depression 
The research reviewed in this paper investigates associations between genetic 
variation in the human oxytocin system and depression. The oxytocin system’s role in 
depression has been previously supported through evidence from non-human models, 
drug studies, associations between endogenous oxytocin levels and depression, 
administration of oxytocin and reduced depression symptoms, and studies of gene 
expression and epigenetics. 
Non-Human Animal Models  
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Learned-helplessness paradigms such as the forced swim test (FST) model 
depression in mice and rats, based on similar behavioral and neurological correlates 
(Porsolt, Le Pichon, & Jalfre, 1977). After oxytocin administration, both mice and rats 
spend more time continuing to swim, rather than giving up and remaining immobile 
(Arletti et al., 1995; Arletti & Bertolini, 1987). The FST also stimulates release of 
oxytocin in the amygdala in rats, and an oxytocin receptor antagonist led to increased 
immobility that is considered depressive-like behavior (Ebner, Bosch, Krömer, 
Singewald, & Neumann, 2005). Oxytocin administration also reduces learned 
helplessness in a paradigm where rats fail to take advantage of an escape option from a 
shock box after previously not being able to escape (Arletti & Bertolini, 1987). 
Intracerebral oxytocin administration has also show antidepressant-like effects on a 
similar learned-helplessness paradigm known as the tail suspension test (TST), where 
oxytocin administration extends the amount of time before mice give up trying to escape 
(Ring et al., 2010). 
Further evidence that oxytocin is associated with mood in non-human animal 
models suggests that oxytocin has rewarding properties that reduce risk of anhedonia, a 
key depression symptom where individuals are unable to experience pleasure. When rats 
are repeatedly administered subcutaneous oxytocin in a specific place, they show a 
preference for spending time in that place (a paradigm commonly used to evidence the 
rewarding effect of drugs such as cocaine; Liberzon, Trujillo, Akil, & Young, 1997). 
Mice did not show this conditioned place preference when administered intracerebral 
oxytocin infusion (Qi et al., 2009); however, injecting oxytocin into the ventral tegmental 
area (VTA), ventral subiculum and posteromedial cortical nucleus of the amygdala leads 
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to increased dopamine release in reward regions, which supports the connection between 
oxytocin and reward (Wise, 2002). 
Drug Studies 
Oxytocin levels can also be manipulated pharmacologically, such as the use of 
sildenafil, which increases oxytocin release and has been used to treat sexual dysfunction. 
Administration of this drug to mice decreases depression-like behavior in which the mice 
show learned-helplessness, giving up escape attempts during the forced swim test. 
Sildenafil decreases depression-like behavior through action on oxytocin receptors, as 
evidenced by the antidepressant ineffectiveness in oxytocin receptor knockout mice, or 
mice treated with an oxytocin receptor antagonist, Atosiban (Matsushita et al., 2012). 
Endogenous Oxytocin 
Some evidence suggests that plasma oxytocin levels are lower in depressed 
patients compared to healthy controls (Yuen et al., 2014); however, metanalytic data does 
not support this association (Engel et al., 2019). Although peripheral oxytocin 
concentrations may be associated with oxytocin levels in the central nervous system, it is 
unclear whether these levels accurately reflect neurotransmission of oxytocin (Valstad et 
al., 2017). Central nervous system oxytocin may be particularly relevant to depression 
because oxytocin in the ventral tegmental area is directly associated with dopaminergic 
activity in nucleus accumbens, which regulates reward, and thus is associated with mood 
(Shahrokh, Zhang, Diorio, Gratton, & Meaney, 2010), as reduced sense of reward is a 
common symptom of depression (Treadway & Zald, 2011). Studies measuring oxytocin 
in cerebral spinal fluid provide stronger evidence for central nervous levels of oxytocin, 
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and these cerebral spinal fluid oxytocin levels are associated with suicide intent and 
behaviors (Jokinen et al., 2012; R. Lee, Ferris, Van de Kar, & Coccaro, 2009). 
Administering Oxytocin 
Intranasal and peripheral administration of oxytocin increases central oxytocin 
levels (Neumann, Maloumby, Beiderbeck, Lukas, & Landgraf, 2013). Administration of 
intranasal oxytocin is associated with reduced depression symptoms and increased well-
being (Scantamburlo, Hansenne, Geenen, Legros, & Ansseau, 2015). However, mothers 
with post-partum depression reported increased sadness during a week of intranasal 
oxytocin administration, despite reporting a closer bond with their baby, relative to when 
they were taking a placebo (Mah, Van Ijzendoorn, Smith, & Bakermans-Kranenburg, 
2013). Although administering intranasal oxytocin can be associated with decreased 
depression symptoms, increased well-being, and more positive relationship between 
mothers and infants, the increased sadness after administration in depressed mothers 
highlights the importance of considering the varying dimensions of depression 
symptomology in association with oxytocin.  
Gene Expression and Epigenetics 
DNA methylation associated with decreased OXTR expression (Gregory et al., 
2009) is associated with increased risk of postpartum depression (Bell et al., 2015; 
Kimmel et al., 2016). Methylation of exon 1 of OXTR is decreased in women with 
depression compared to healthy controls (Reiner et al., 2015). Methylation in the 
promotor region of OXTR mediates the association between adult adversity and negative 
cognitive schemas such as pessimism and distrust in a path to depression symptoms, 
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implicating epigenetic changes and subsequent reduction in OXTR expression as a 
potential biological mechanism for adversity’s effect on depression-related negative 
cognitive biases (Simons, Lei, Beach, Cutrona, & Philibert, 2017). 
Genetic Variation in the Oxytocin System 
Oxytocin neurotransmission depends on proteins involved in synthesis, neural 
secretion, post-synaptic signaling, and degradation of oxytocin; therefore, genetic 
variation in the genes for these proteins may play a role in individual differences in 
oxytocin signaling. Although this system interacts closely with serotonin, norepinephrine, 
dopamine, and growth factors (McQuaid, McInnis, Abizaid, & Anisman, 2014), only 
proteins with direct and specific effects on oxytocin signaling are considered part of the 
oxytocin system for this review, as done in previous reviews of oxytocin-related genetic 
variation (Feldman, Monakhov, Pratt, & Ebstein, 2016). Oxytocin system components 
are shown in Figure 3.1. These are the genes that are commonly considered to be part of 
the oxytocin pathway (Feldman et al., 2016). Variation in the genes coding for these 
components can likely alter signaling of oxytocin through their effects on production of 
the proteins and have been associated with social behaviors and mood. The biological 
effects of nonsynonymous SNPs, in which alternative alleles result in the substitution of a 
different amino acid during translation, can impact the structure, and thus efficacy, of the 
protein (Ramensky, Bork, & Sunyaev, 2002). Synonymous SNPs, alternatively, can 
reduce protein production through reduced transcription (Hunt, Sauna, Ambudkar, 
Gottesman, & Kimchi-Sarfaty, 2009). Sequence variation can also alter susceptibility of 
the locus to epigenetic changes (e.g. methylation), which can reduce transcription and 
gene expression (Turan et al., 2010). The functional effects of specific variants are not 
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always known, leaving the possibility that any identified associations are attributable to 
linkage equilibrium with a functional variant.  
 
Figure 3.1. Diagram of an oxytocinergic synapse, indicating several proteins that 
influence the neurotransmission of oxytocin. The OXT gene codes for a precursor that is 
important for synthesis of oxytocin, the CD38 gene codes for a protein that increases 
neurosecretion of oxytocin, the OXTR gene codes for the receptors that respond to 




Oxytocin Receptor Gene, OXTR 
OXTR codes for the oxytocin receptor and includes approximately 17 kilobases 
containing 3 introns and 4 exons on chromosome 3p25.3, chr3:8,794,662- 8,809,873 
(reverse strand; Inoue et al., 1994). Variation in OXTR has been studied extensively, 
particularly in association with socially-relevant phenotypes such as responsiveness to 
social support (Chen et al., 2011), social recognition skills (Skuse et al., 2014), and 
autism spectrum disorder (Jacob et al., 2007). One SNP (rs2268498) within the promotor 
region of OXTR has verified functional outcomes, with higher mRNA expression 
associated with the C allele (Reuter et al., 2017). Most OXTR SNPs are located in non-
coding intronic regions with unknown effects on the resulting structure or function of the 
OXTR. Differential methylation of a CpG island within the third intron of OXTR is 
associated with differences in transcription and OXTR expression in the cortex (Gregory 
et al., 2009), so differential susceptibility to epigenetic modification may explain why 
SNPs in this region are associated with context-dependent behavioral outcomes. Other 
SNPs in intronic regions that contain an active enhancer (such as rs237887) may be 
associated with differential transcription factor binding affinities, altering OXTR 
expression. Variation in this gene is a primary candidate for associations with depression. 
Oxytocin Gene, OXT 
The OXT gene on chromosome 20p13, (GRCh38): 20:3,068,870-3,072,516, codes 
for the precursor protein oxytocin-neurophysin-I and is associated with oxytocin levels in 
plasma and the brain (See Figure 3.2). Variation in the OXT gene has been associated 
with sociability (Haas et al., 2016) and social withdrawal in children (S. M. Francis et al., 
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2016) and epigenetic modification of OXT revealed associations with adult attachment 
style and recognition of emotional faces (Haas et al., 2016). 
 
Figure 3.2. Chemical pathway for synthesis of oxytocin from neurophysin I. The OXT 
gene codes for the precursor protein oxytocin-neurophysin-I.  
 
Oxytocinase Gene, LNPEP 
The leucyl-cystinyl aminopeptidase (LNPEP) gene on chromosome 5p15, 
(GRCH38): 5:96,934,858-97,037,512, codes for an enzyme that preferentially degrades 
oxytocin in the basal ganglia, cerebral cortex, and cerebellum (Tsujimoto & Hattori, 
2005). Genetic variation associated with higher production of LNPEP would be 
associated with more degradation of oxytocin and thus less oxytocin available for 
neurotransmission (Matsumoto et al., 2001). Currently, associations with variation in 
LNPEP are extremely limited. The SNPs rs18059 and rs4869317 are associated with 
mortality in patients with septic shock, and the rs4869317 T/T genotype is associated 
with increased plasma vasopressin clearance (because the enzyme degrades vasopressin 
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as well; Nakada et al., 2011). However, hypotheses regarding the likely connection 
between LNPEP and behavioral outcomes remain untested by currently published 
studies.  
Cluster of Differentiation 28 Gene, CD38  
The CD38 gene contains more than 80 kilobases with 8 exons on 4p15, 
(GRCh38): 4:15,778,327-15,853,231. It codes for cluster of differentiation 38, a 
glycoprotein associated with immune response and cell activation. Relevantly, CD38 
produces an enzyme which regulates the release of oxytocin, so increased expression of 
CD38 yields an increased release of oxytocin. Loss of CD38 function is associated with 
social amnesia (Higashida et al., 2012). 
Rationale and Aims 
Oxytocin has received extensive attention recently, producing over 7,000 hits 
from the past 10 years on a search of PubMed. The evidence justifying the connections 
between the oxytocin system and different facets of social behavior has already been 
reviewed extensively. Reviews have broadly discussed the role of oxytocin in affiliative 
behavior (Insel, 2010), more specifically established an association between intranasal 
oxytocin and social cognition (Graustella & MacLeod, 2012), and even genetic variation 
in the oxytocin system and social behavior (Kumsta & Heinrichs, 2013). Only one recent 
review has summarized associations between endogenous oxytocin levels and depression 
(Engel et al., 2019), but it included assessments of endogenous oxytocin levels and not 
evidence for genetic variation in the oxytocin system. An older review had a much more 
comprehensive summary of the role of the oxytocin system in depression, but only briefly 
mentioned one study assessing human genetic variation (Slattery & Neumann, 2010). The 
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current review is therefore crucial to understand current perspectives on how genetic 
variation in the oxytocin system might play into risk of depression, what types of genetic 
methods previous studies have used, and which social variables have been accounted for 
in previous studies. The critical need for understanding biological systems associated 
with depression symptoms relies on a careful evaluation of common methodology and 
previous findings.   
With rapid development in genotyping technologies, researchers and clinicians 
are pushing for a better understanding of the genetic contributions to health care issues 
such as depression, considering potential genetic-based tools for screening, prevention, 
diagnosis, and treatment (Jameson & Longo, 2015). Identifying genetic variation 
associated with mental illness serves several important purposes including providing 
information regarding the biological system involved in pathology and understanding 
individual differences in susceptibility (Serretti, 2018).  
Despite years of research pursuing the genetic architecture of mental illnesses, the 
evidence has limitations. Complex phenotypes like behavioral traits and mental illnesses 
are highly polygenic, so evidence implicating individual or small numbers of 
polymorphisms in these phenotypes suffers from weak effect sizes and often failure to 
replicate (Duncan & Keller, 2011). Additionally, the numerous non-genetic factors that 
contribute to these behavioral phenotypes can contribute to the difficulty with replication 
and weak effect sizes (Billings, Cronkite, & Moos, 1983). While hypothesis-driven 
candidate gene studies fail to capture the vastly polygenic nature of traits like depression, 
genome-wide approaches often struggle to identify variants that meet the stringent 
threshold for statistical significance or have any known biological significance.  
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Genetic associations with depression also often suffer from a poorly specified 
phenotype. Categorical diagnosis status is inherently problematic when symptoms 
severity and type are as variable and relevant as in the case of depression; yet many 
genetic studies still use diagnosis as a phenotype. Additive scores of symptoms still fail 
to capture the varied, multidimensional nature of depression (Fried & Nesse, 2015). The 
symptoms of depression vary greatly, so any two people with the disorder may have 
vastly different symptoms and biological contributions; thus, some researchers are 
advocating for a network analysis approach that allows investigation of which symptoms 
are and are not associated with the pathway under investigation (Borsboom, 2017; 
Borsboom & Cramer, 2013). 
While acknowledging the limitations and trade-offs in behavior genetics research, 
these research approaches support the current movement toward treatments that consider 
individual differences, termed “personalized medicine” (Vogenberg, Isaacson Barash, & 
Pursel, 2010). This approach recognizes that the numerous available treatment options do 
not have equal efficacy for different people, and individual differences in biological 
systems may play an important role. More recently, this movement has been more 
accurately rebranded as “precision medicine” and has become an important direction for 
treatment of psychiatric disorders (Jameson & Longo, 2015; Serretti, 2018). Early uses of 
precision medicine focused on oncology and helped identify individual differences in 
metabolism of drugs, providing more accurate dosage recommendations and 
understanding of drug toxicity (Verma, 2012). Investigations regarding what treatments 
work best for people with various genetic profiles have already been guiding treatment 
options for alcohol dependence (Sun et al., 2016) and other psychological diagnoses 
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(Serretti, 2018), but further understanding of the role of genetics in psychological 
disorders is essential for these goals.  
Because of its high prevalence, mortality, morbidity, and heritability (single 
episode of major depressive disorder estimated around 30% heritability, and recurrent 
MDD was much higher; Fernandez-Pujals et al., 2015), depression is a common focus of 
behavior genetics research. Precision medicine for depression is particularly crucial 
considering the wide array of different medications that have differential efficacy across 
individuals (Mulrow et al., 2000) and the many people with depression that remains 
resistant to current treatment options (Thomas et al., 2013). Although the oxytocin 
system has received some attention as a potential target for depression treatment 
(Matsushita, Latt, Koga, Nishiki, & Matsui, 2019), further understanding the specific role 
of genetic variation in this system in association with depression would better 
characterize individual differences in depression symptoms. Depression symptoms vary 
so much across individuals that it often looks like completely different disorders (Fried & 
Nesse, 2015), so if the oxytocin system is associated with depression, a comprehensive 
understanding of this association may help identify which symptoms of depression are 
associated with functioning of this system, as opposed to other likely candidates like the 
serotonin system. A careful consideration of the current evidence for an association 
between oxytocin genetic variation and depression is critical for guidance of 
methodological decisions and variant selection in further research. 




Methodological heterogeneity complicates the evidence regarding associations 
between genetic variation in the oxytocin system and depression. Results are often not 
generalizable across contexts, especially when effect sizes are weak (Duncan & Keller, 
2011). Without a comprehensive review, it is unclear which variants are associated with 
depression in which contexts using which research methods. Results may differ based on 
which variant(s) in which gene(s) are included in a study. Different measures of 
depression or symptoms of depression may also yield different results (Roberts, 
Lewinsohn, & Seeley, 1991). Consideration of social context is integral in oxytocin 
system functioning, so studies that include some type of social experience variables likely 
find different effects as well (Bartz, Zaki, Bolger, & Ochsner, 2011). 
Genetics research targeting a specific biological system sometimes focuses on a 
single variant in a relevant gene, but small effect sizes and the polygenic nature of 
complex behavioral outcomes can make these associations hard to capture (Duncan, 
Ostacher, & Ballon, 2019). Other studies find associations when using a polygenic score, 
but few of the variants are associated with depression if investigated individually 
(Schneiderman, Kanat-Maymon, Ebstein, & Feldman, 2013). Potential for linkage 
disequilibrium is also crucial to interpreting biological interpretation of results, 
considering associations may be due to a different variant in linkage disequilibrium with 
the identified variant (Ardlie, Kruglyak, & Seielstad, 2002). 
In addition to a multitude of different ways of assessing MDD diagnosis (Roberts 
et al., 1991), some researchers advocate for a more dimensional assessment across a 
spectrum of depression symptoms rather than binary classification or a single continuous 
additive score of symptoms (Rush, 2007; Kircanski et al., 2017; Fried & Nesse, 2015). 
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Even subclinical depression symptoms are associated with 2-3 times higher risk for major 
depressive disorder later in life (Pine et al., 1998), increased risk for substance abuse 
(Sofuoglu et al., 2001), difficulties in social adjustment and self-efficacy, lower academic 
performance (Deroma et al., 2009), and lower life satisfaction (J. I. Lee et al., 2003). 
Furthermore, certain depression symptoms are distinct from one another in etiology and 
resulting impairment; for example, loss of loved ones is associated with sadness, 
anhedonia, and appetite loss, whereas chronic stress and experiencing failures is more 
associated with fatigue and hypersomnia (Keller, Neale, & Kendler, 2007), so 
understanding relevant biological factors may depend upon investigating symptoms 
separately. Sums of all depression symptoms, especially when drawing somewhat 
arbitrary clinical cutoffs, imply depression is a single unidimensional disorder rather than 
the more strongly-supported likelihood that the symptoms are loosely-connected and may 
not always share common causes or outcomes (Fried & Nesse, 2015). Focusing on a 
multi-dimensional approach aligns with current shifts toward using the Hierarchical 
Taxonomy of Psychopathology (HiTOP) for psychiatric genetics (Kotov et al., 2021), 




The systematic review followed Preferred Reporting Items for Systematic 
Reviews and Meta-Analyses (PRISMA; Moher, Liberati, Tetzlaff, Altman, & Group, 
2009) guidelines. The literature search used PubMed and PsychInfo, because these 
databases are the most commonly used databases for biological psychology articles and 
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cover a comprehensive list of the relevant journals. Within each database, the search 
terms “Oxytocin AND Depression AND Genetics,” were included in the search. Article 
titles were screened for potential relevance and articles that were not related to oxytocin, 
depression, and genetics were eliminated. Abstracts of articles with relevant titles were 
then screened using the eligibility criteria. Any article that was not clearly disqualified 
based on title or abstract was read to determine eligibility. The search was conducted on 
October 10th, 2019. 
Eligibility Requirements 
Studies that tested an association between genetic variation in an oxytocin-related 
gene and some measure of depression or depressive symptoms were included (depressive 
mood, suicidality, internalizing symptoms, depression-like behavior and similar variables 
were included, but brain activity and responsiveness to happy vs. sad faces were not). 
Gene knock-out studies and studies that measured methylation, mRNA levels, or 
oxytocin levels without measuring any genomic variance were excluded; only studies that 
measured genomic variation in humans were included. Studies were not excluded on the 
basis of population, so all human samples of clinical and post-partum populations were 
eligible. Studies that met criteria were all candidate gene studies, which have marked 
limitations due to small effect sizes and poor replication rate, but when summarized 
together and assessed for quality, are essential for guiding future hypothesis testing 
regarding the implication of this biological system in depression symptoms. In reviewing 
the evidence for associations between genetic variation in each oxytocin-relevant gene, 
we report both the number of studies reporting an association, and the strength of that 
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evidence, addressing the likelihood of false-positives. Figure 3.3 shows the review 
decision path. 
Figure 3.3. PRISMA flow diagram of systematic review process. A total of 180 hits 
using the search terms “Oxytocin AND Depression AND Genetics” were identified 
across PsychINFO and PubMed. There were 33 studies among those that met criteria for 
inclusion in the systematic review. 
 
Results 
As shown in Supplementary Table 1, 33 studies met eligibility requirements. 
Studies investigated genetic variation in OXTR, OXT, and CD38. There were a variety of 
methodologies implemented with regards to genetic analysis (e.g. number of variants 
included), statistical power, depression measurement, and inclusion of potential 
interactions. Studies varied widely in their target population and main focus of the study, 
with some only testing the association between oxytocin system genetic variation and 
depression as a secondary analysis. 
Genetic Variation in the Oxytocin System Identified 
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Studies investigated genetic variation in OXTR, OXT, and CD38. None of the 
studies included any variants in LNPEP. Figure 3.4 shows the number of studies with 
positive, conditional (effects only present in subsets of population or in presence of 
certain environmental contexts), and negative findings for each SNP tested. 
 
Figure 3.4. Number of studies finding significant, conditional, and non-significant 
results for each SNP in OXTR, OXT, and CD38. For each SNP, the blue bar indicates 
the number of studies that tested the SNP and found a significant association with 
depression. The orange bar indicates the number of studies that found a conditional effect 
of the SNP that was relevant to depression. The grey bar indicates the number of studies 
that found no association between the SNP and depression. SNPs that were only tested in 
one study and had no significant or conditional effect are not included in the figure. 
 
Oxytocin Receptor Gene (OXTR) 
Genetic variation in OXTR was the most commonly tested and most commonly 
supported in association with depression. The most studied polymorphism was OXTR 
rs53576, which was assessed in 71% (24) of the 34 studies, 17 of which failed to assess 
any other polymorphisms in the oxytocin system. OXTR SNP rs2254298 was the next 
























































































































































































rs1042778, and two each for the OXTR SNPs rs1331619, rs2268490, rs4813627, 
rs2268493, rs113114, and rs2268491. Almost all the studies (32) tested at least one 
variant in OXTR. 
Despite the number of studies investigating SNPs in OXTR and even the number 
finding a significant association with depression symptoms (13 studies found significant 
main effects on depression for at least one OXTR SNP, and several more found 
associations in subsets of the sample, or interaction effects), it is important to consider the 
strength of the evidence in these studies. The study with arguably the strongest 
methodology and statistical power of 2,567 participants found no association between 
OXTR SNPs rs2254298, rs53576, or rs2268298, which were some of the variants with 
strongest support in other studies (Tollenaar et al., 2017). Another study with strong 
methodology and 1,185 participants found that rs53576 is only associated with lower end 
of depression symptoms in males of their Polish population (Wasilewska et al., 2017). 
This suggests that the association between rs53576 identified in many other studies may 
be present, but only in specific contexts for some individuals. The seemingly stronger 
associations found in other studies may be partially attributed to methodological 
differences in the studies’ measurements of depression, other variables controlled for, or 
sample, but may also be due to false positives or exaggerated effect sizes due to chance in 
small sample sizes. Significant effects found with this SNP were in association with self-
report measures of depression symptoms (e.g. Cicchetti & Rogosch, 2012; Saphire-
Bernstein, Way, Kim, Sherman, & Taylor, 2011; Wang et al., 2019), depression diagnosis 
(Adrian et al., 2015; Costa et al., 2017; Costa et al., 2009), and suicide attempt history 
(Parris et al., 2018). These studies with significant effects had sample sizes ranging from 
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185 (Costa et al., 2009) to 611 (Wang et al., 2019), with most falling between 300-500 
participants. 
The evidence for an association between OXTR rs237885 and depression is 
present, but weak. Most of the studies testing this association were underpowered 
(samples under 200 participants), and therefore although there is an association between 
genotypes of this SNP and prepartum depression (Mileva-Seitz et al., 2013), with 187 
participants), this finding may be a false positive. Other studies failing to find a 
significant association may have been underpowered as well, due to small effect sizes, 
leading to false negatives (e.g. Comasco et al., 2016, with 170 participants). A more 
strongly-powered family study (with 678 probands) did not find an association between 
rs237885 genotypes and childhood-onset mood disorders (Strauss et al., 2010). With no 
consistency in measurement or types of depression, it is unclear whether there may be a 
weak, context-dependent association between an OXTR SNP and certain elements or 
types of depression. 
Oxytocin Gene (OXT) 
OXT SNPs rs2740210 and rs4813627 were also among the most studied SNPs, 
with three studies including each. However, these were the only SNPs in OXT studied in 
any of the papers reviewed, and the only effects with depression were conditional on 
other factors such as early life experience (Jonas et al., 2013; Mileva-Seitz et al., 2013).   
Cluster of Differentiation 38 Gene (CD38) 
Only two studies tested for an association between genetic variation in CD38 and 
depression, both investigating the SNP rs3796863. Neither of the studies measuring 
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rs3796863 genotype found a significant main effect of genotype on depression measures. 
Only when considering interactions with other variables such as chronic interpersonal 
stress, was this genotype important for depression risk (Tabak et al., 2016).  
Methodological Variation 
Number of Variants Included 
Of the 34 studies reviewed, 65% (22) only investigated genotype of one SNP. A 
total of 20% (7) tested two or three SNPs, 9 % (3) assessed 5-7 SNPs, and 6% (2) 
assessed more than 40 SNPs (see Figure 3.5). Of the studies that assessed genotype of 
multiple SNPs, most tested associations with each SNP separately, one used a polygenic 
risk score, and one used a haplotype analysis. The adjustment for multiple comparisons 
resulted in lack of statistical power to detect a significant effect in some studies (e.g. 
Strauss et al., 2010). Most studies used samples of unrelated individuals, but 2 studies 





Figure 3.5. Number of SNPs investigated in each study. Most studies (21) investigated 
only one SNP, and very few studies (4 total) included more than 3 SNPs. 
 
Different Ways of Measuring Depression  
Measures of depression varied across studies (See Figure 3.6). Most studies (26) 
used some continuous measure of depression symptoms, but different scales for 
depression symptoms were used, and some combined depression measures with other 
related symptoms scales and others used internalizing symptoms or mood assessments in 
lieu of measures specific to depression symptoms. The most common measures of 
depression symptoms were the Beck Depression Inventory (BDI), which was used in 7 
studies, and the Children’s Depression Inventory (CDI), which was used in 5 studies, and 
the Center for Epidemiologic Depression Scale (CES-D), which was used in 4 studies. 
None of the studies used any form of network analysis to identify which symptoms might 
66 
 
be particularly associated with genetic variation; these sorts of approaches may help 
determine if the oxytocin system is implicated specifically in certain elements of 
depression or types of depression (Borsboom, 2017; Borsboom & Cramer, 2013). 
 
Figure 3.6. Measurements of depression used in analyses. Most studies, 26 (72%) used 
a quantitative score of depression symptoms from either self-report questionnaires, 
interviews, or some combination. One-fifth of studies used a categorical diagnostic 
criteria for their analysis. A few studies (3) used either suicide victims or people with a 
history of suicide attempts compared to healthy controls for the analysis. 
 
Inclusion of Social Factors and Testing for Interactions 
Although most of the studies investigated associations between genetic variation 
in the oxytocin system and depression in context of an environmental stressor, the other 
factors included vary widely across the studies included in this review. Some of the 
studies considered the association in combination with other disorders such relational 
aggression, disruptive disorder. Many of the studies looked at interactions with some 
form of childhood traumatic experience, including general childhood maltreatment 
(Hostinar, Cicchetti, & Rogosch, 2014; Jonas et al., 2013; Myers et al., 2014), parental 
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divorce in adolescence, maternal depression (Windle & Mrug, 2015), quality of early life 
care (Mileva-Seitz et al., 2013), attachment style (Parris et al., 2018). Others looked at 
more chronic or later life stress (Tabak et al., 2016) or unsupportive social interactions 
(McInnis, McQuaid, Matheson, & Anisman, 2015). Only a couple of studies focused on 
interactions between genetic variation in the oxytocin system and positive social 
experiences such as social support (Hostinar et al., 2014) or spirituality and religion 
(Anderson et al., 2017). Because the oxytocin system is so highly related to social 
behavior (Kumsta & Heinrichs, 2013), many associations between genetic variation in 
the oxytocin system and depression symptoms may be contingent upon the presence of 
particular social conditions, so including more of the relevant social experiences in a 
single study could help disentangle these complex factors. 
Figure 3.7. Frequency distribution of sample sizes. Only 3 of the studies surpassed the 
recommended threshold of 1,000 participants for candidate gene association studies. M = 





There is evidence that genetic variation in the oxytocin system may be associated 
with depression symptoms, but this effect is likely weak, polygenic, context dependent, 
and sensitive to numerous specifics of research methodology. There is currently little 
evidence that meets current standards for sample size of at least 1,000 for candidate gene 
association studies (Duncan & Keller, 2011). Sample sizes of the studies ranged from 40 
to 2,567 (M = 452.5), and only three of the studies reviewed surpassed the recommended 
sample size of 1,000 (Costa et al., 2017; Hostinar et al., 2014; Kawamura et al., 2010; 
Onodera, Ishitobi, Tanaka, Aizawa, Masuda, Inoue, Oshita, Okamoto, Kawashima, 
Nakanishi, et al., 2015; Reiner et al., 2015; Riem, Pieper, Out, Bakermans-Kranenburg, 
& van IJzendoorn, 2010; Tollenaar et al., 2017; Wasilewska et al., 2017). See Figure 3.7 
for frequency distribution of sample sizes. 
Other methodological variation likely contributed to the lack of consensus among 
the studies reviewed. Eight of the studies studied only children or adolescents, while most 
studied adults, and the factors that contribute most to depression differ among different 
age groups (Schaakxs et al., 2017). Effects in children appeared to be more common than 
adults, suggesting that genetics may play a stronger role in responses to early life 
experience. Many of the significant genetic effects identified were only found in context 
of specific environmental factors, but the environmental factors measured differed greatly 
across the studies, and because of the importance of oxytocin in social behavior, 
measuring a variety of these variables is crucial (Kortesluoma & Karlsson, 2011). 
Despite strong evidence that complex traits like depression are likely influenced 
to a small degree by many genes, with effect sizes that often fail to meet statistical 
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significance in large scale Genome Wide Association Studies (GWAS; Maul et al., 
2019), most studies exploring this association only investigated one variant, and only five 
studies included more than 3 SNPs. Furthermore, several of the studies that included 
multiple SNPs tested associations with each SNP separately, which in some cases led to 
loss of significance due to adjustment for multiple testing (e.g. Strauss et al., 2010). 
Including multiple well-supported variants in a polygenic score can help strengthen the 
association and reduce the number of independent comparisons necessary (Di Iorio et al., 
2017). 
Several studies found null effects for at least some of the hypothesized 
associations between genetic variants in the oxytocin system and depression symptoms 
(e.g. Riem et al., 2010; Wang et al., 2019). Some of these studies had large sample sizes 
and strong methodology (e.g. Tollenaar et al., 2017). Although it is possible that some of 
the associations found in studies with small sample sizes may have been false positives, 
considering the strength of other studies with significant effects (e.g. Myers et al., 2014; 
Onodera, Ishitobi, Tanaka, Aizawa, Masuda, Inoue, Oshita, Okamoto, Kawashima, & 
Nakanishi, 2015; Wasilewska et al., 2017) and the convergent evidence, differences in 
results across studies are likely due to the fact that genetic effects are subtle and not 
resilient across the varying context in the studies. 
 GWAS are a powerful tool for identifying SNPs that are associated with an 
outcome that have become the preferred method, attempting to solve several significant 
limitations of candidate gene association studies in finding association between genetic 
variation and psychological disorders in humans (Duncan et al., 2019). Because GWAS 
takes a non-hypothesis driven approach to identifying which variants are most associated 
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with an outcome, the biological significance of SNPs identified through GWAS are not 
always readily apparent, and they do not often replicate associations identified in 
candidate gene association studies. Discrepancies between results may be related to 
loosely defined phenotypes, varying populations, and the difficulty in detecting very 
small, context-dependent effects. Thus, careful selection of narrowly-defined phenotypes 
and validation of candidates remains important (Korte & Farlow, 2013). 
Across 17 GWASs looking at major depressive disorder, none identify any SNPs 
in the oxytocin system (Maul et al., 2019). Other biological systems that have been 
strongly implicated in depression such as the serotonin system are also notably absent 
from these GWAS findings. Because of the vast number of SNPs being tested in GWAS, 
the multiple testing creates a high threshold for significance, leading many GWAS to fail 
to find any significant effects and fail to replicate variants identified by other GWAS  
(Korte & Farlow, 2013). Variants that have been replicated by GWAS point to some 
good candidate genes including RERE, VRK2, RSRC1, PUM3, SORCS3, OLFM4, BAG5, 
DCC, L3MBTL2 (Howard et al., 2018; Maul et al., 2019). However, the physiological 
mechanisms that might connect these genes (and non-encoding regions of the genome 
that are associated with MDD in GWAS) to pathology are generally not understood, and 
biologically-informed hypotheses based on understanding other specific biological 
systems that have been implicated in depression remain useful, considering that research 
on serotonin and depression has informed effective treatments (Geddes, Freemantle, 
Mason, Eccles, & Boynton, 1999).  
Recommendations for Future Research 
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The evidence in this review suggests that there is still a need for properly-
powered investigations of associations between oxytocin system genetic variation and 
depression using a polygenic score including several of the SNPs with the strongest 
current evidence. OXTR rs53576, OXTR rs2254298, OXTR rs1042778, OXT rs237885, 
and CD38 rs237885 may be good candidates for inclusion in polygenic scores, especially 
if social context is considered (Kumsta & Heinrichs, 2013). The current evidence also 
lacks careful attention to how the association may differ among various symptoms of 
depression. Therefore, future research should investigate symptoms separately, since the 





CHAPTER 4: GENETIC VARIATION IN THE OXYTOCIN SYSTEM IS NOT 
ASSOCIATED WITH SOCIAL RESPONSIVENESS OR DEPRESSION SYMPTOM 
SEVERITY 
Abstract 
This study tested associations between a polygenic score aggregating genotypes 
of SNPs in the oxytocin system with depression symptom severity and social 
responsiveness traits. We selected 8 SNPs in OXTR, one in OXT, and one in CD38 based 
on the evidence in Chapter 3 and evidence for biological correlates and interactions with 
social experiences. Using data collected from 1,128 undergraduate participants who 
completed surveys and donated buccal cells for genetic analyses, the polygenic score was 
not associated with depression symptom severity, rejection sensitivity, need to belong, 
dispositional empathy, self-monitoring, or alexithymia. It did moderate an association 
between a net social experience score that aggregated perceived social support, perceived 
discrimination, childhood trauma, and sexual objectification with depression symptom 
severity. However, this effect did not survive multiple-testing adjustments and there was 
no moderation of the effects of individual social experiences. The polygenic score did not 
play any role in models connecting social network size to depression symptom severity 
via perceived social support. Overall, this study found no evidence for a robust role of 
genetic variation in the oxytocin system in depression symptom severity even in context 
of responsiveness to several social experiences. Understanding the role of genetics in 
depression symptoms may depend on considering multiple biological systems 
simultaneously. Measurements of peptide levels and sympathetic nervous activity may be 
more strongly associated with complex behavioral outcomes than genetic variation. 
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Genetic variation in the oxytocin system is not associated with Social Responsiveness or 
depression symptom severity 
The high morbidity and mortality associated with depression remains a significant 
issue worldwide with an estimated 8.5% of adults in the United States reporting 
clinically-significant levels of depression before the COVID-19 pandemic; this risk 
increased more than threefold in spring of 2020, so concerns about addressing symptoms 
of depression remain high (Ettman et al., 2020). Despite research identifying many 
genetic and experiential risk factors, genetic associations are often dependent on context, 
contributing to weak and unclear associations (Ağır, 2019; Niu et al., 2016). The current 
study investigates genetic variation in the oxytocin system, which has previously had 
tenuous evidence for its association with depression symptoms, in context of social 
experiences that are likely to interact with this biological system. We also test current 
theories regarding a mechanism for oxytocin genetic variation’s potential role in the 
buffering effect of social support on depression symptoms. 
Behavioral Relevance of Genetic Variation in the Oxytocin System 
Although associations between genetic variation and individual differences in 
behavior can be subtle, complex, and depend on a wide array of interactions with other 
genetic and environmental factors, associations between the oxytocin system and social 
behavior are well-established (Kumsta & Heinrichs, 2013). Variation in genes that make 
proteins involved in synthesis, neural secretion, post-synaptic signaling, and degradation 
of oxytocin are relevant to neurotransmission of this neuropeptide and have potential 
relevance to behavioral phenotypes. The components that have been identified as part of 
74 
 
the oxytocin pathway are coded for by OXT, OXTR, CD38, and LNPEP (Feldman et al., 
2016; Kumsta & Heinrichs, 2013).  
The OXT gene codes for a precursor protein oxytocin-neurophysin-I that is 
important for synthesis of oxytocin. Variation in the OXT gene is associated with 
sociability (Haas et al., 2016) and social withdrawal in children (S. M. Francis et al., 
2016) and epigenetic modification of OXT revealed associations with adult attachment 
style and recognition of emotional faces (Haas et al., 2016). The CD38 gene codes for 
cluster of differentiation 38, a protein that increases neurosecretion of oxytocin. Loss of 
CD38 function is associated with social amnesia (Higashida et al., 2012). The OXTR gene 
codes for the receptors that respond to oxytocin. Variation in this gene has is commonly 
studied and includes plenty of evidence regarding its association with socially-relevant 
phenotypes including responsiveness to social support (Chen et al., 2011), social 
recognition skills (Skuse et al., 2014) and autism spectrum disorder (Jacob et al., 2007). 
The leucyl-cystinyl aminopeptidase (LNPEP) gene codes for the enzyme that degrades 
oxytocin in the basal ganglia, cerebral cortex, and cerebellum (Tsujimoto & Hattori, 
2005). Although associations between variation in LNPEP and behavioral phenotypes are 
unknown, the role of this genetic variation in the availability of oxytocin for 
neurotransmission makes it a good candidate (Matsumoto et al., 2001). 
Association Between Genetic Variation in The Oxytocin System and Depression 
Genetic variation in the oxytocin system has been associated with depression in 
some studies, but the evidence is relatively weak. Some studies with large sample size 
and strong methodology report no association between depression and many oxytocin-
related SNPs (Tollenaar et al., 2017). Many other studies testing associations between 
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genetic variation in the oxytocin system and depression only test one genetic variant, and 
sample sizes are often much too small for reliably testing genetic effects (Duncan & 
Keller, 2011). Several studies also use a dichotomous diagnostic criterion rather than a 
spectrum of depression symptom severity or different symptom profiles, leading to 
uncertainty regarding whether failure to find an effect may reflect the limitations of the 
methodology (Fried & Nesse, 2015). 
Despite the tenuous evidence implicating genetic variation in the oxytocin system 
and depression symptoms, significant associations have been identified, especially when 
considering interactions between genetic variants and social factors. In many studies, 
associations between genetic variants in the oxytocin system and depression symptoms 
are only found when considering interactions with childhood trauma (Hostinar et al., 
2014; Jonas et al., 2013; Myers et al., 2014; Windle & Mrug, 2015), later life stress 
(Tabak et al., 2016), unsupportive social interactions (McInnis et al., 2015), or social 
support (Hostinar et al., 2014; Woods et al., 2016). Investigating statistical interactions 
reduces the statistical power relative to main effects, so it is especially crucial to test 
interactions in samples that are sufficiently large, and there is increased likelihood that 
some of the interactions effects detected in smaller sample sizes are unreliable 
(McClelland & Judd, 1993). The most consistent evidence for behaviors associated with 
genetic variation in the oxytocin system are social behaviors, so considering relevant 





The intron variant rs53576 is one of the most studied SNPs in the oxytocin system 
and is associated with individual differences in responses to social experiences; for 
example, people with the G allele tend to have a greater association between social 
support and stress reduction (Chen et al., 2011), and a greater association between 
childhood maltreatment and reduced gray matter (Dannlowski et al., 2016). The rs53576 
variant is also associated with several traits that are likely associated with social 
responsiveness, including emotional processing of social cues (Choi, Minote, & 
Watanuki, 2017), social auditory processing (Tops, Van IJzendoorn, Riem, Boksem, & 
Bakermans-Kranenburg, 2011), and social impairment/cognition/face processing (Parker 
et al., 2014; Slane et al., 2014). 
Although functionality of rs53576 has not been established in humans, similar 
variants in voles have been associated with OXTR density in the nucleus accumbens, a 
region important in social behavior (King, Walum, Inoue, Eyrich, & Young, 2016). 
Intronic variants such as rs53576 may affect gene expression due to differential binding 
of transcriptional factors or by acting as enhancer elements, or associations may be 
explained by linkage disequilibrium with SNPs in the regulatory region. Because the G 
allele is associated with more OXTR density, this is considered the higher oxytocin 
neurotransmission allele. 
OXTR rs1042778 
The T allele of rs1042778 is associated with lower plasma oxytocin levels and 
related behavioral phenotypes such as reduced parental touch (Feldman et al., 2012). The 
G allele is important for binding a transcription factor, so the absence of that transcription 
factor in genotypes with the T allele may reduce transcription levels of OXTR (Ribeiro et 
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al., 2018). The likely reduced number of oxytocin receptors in people with the T allele 
may help explain behavioral correlates such as inhibited sociality (Creswell et al., 2014) 
and callous unemotional traits that reflect less sensitivity toward others and diminished 
empathic response (Dadds et al., 2014). This SNP is a prime candidate for differential 
sensitivity to social cues, because it has already shown that men with the T allele benefit 
less from marital social support, whereas the T allele can also be associated with higher 
marital quality via other paths (Mattson et al., 2019).  
The G allele of rs1042778 is important for binding a transcription factor and the T 
allele may reduce transcription levels of OXTR (Ribeiro et al., 2018). The T allele is also 
associated with lower plasma oxytocin levels (Feldman et al., 2012). Thus, the G allele is 
considered the higher oxytocin neurotransmission allele. 
OXTR rs237887 
The SNP rs237887 is located in an intronic region that likely contains an active 
enhancer. Data suggest that this region is associated with differential patterns of DNAase 
hypersensitivity and binding affinity of transcription factors. This evidence suggests a 
potential mechanism by which this SNP could alter gene expression patterns, thus 
explaining associations with behavioral traits such as social recognition skills (Skuse et 
al., 2014). The G allele is associated with higher transcription, higher responsiveness to 
social faces, and higher empathic distress, but the A allele has higher perspective taking 
empathy (Wu, Li, & Su, 2012). The higher transcription of the OXTR results in higher 




The T allele of rs2268498 is associated with higher empathic concern (Christ, 
Carlo, & Stoltenberg, 2016). Preliminary evidence suggests that children with the T/T 
genotype report more life satisfaction after a positive psychology intervention, whereas 
children with the C allele do not show changes in life satisfaction (Pluess & Belsky, 
2015). This evidence for vantage sensitivity emphasizes the likelihood that this genetic 
variation may interact with social experiences as well.  
This SNP is located in the promotor region of OXTR, allowing it to have direct 
functional effects, which have been verified empirically (Reuter et al., 2017). The T allele 
has higher transcription, thus more oxytocin receptors, and is considered the higher 
oxytocin neurotransmission allele. 
OXTR rs7632287 
The SNP rs7632287 has been reliably associated with social phenotypes in autism 
spectrum disorder (Harrison, Gamsiz, Berkowitz, Nagpal, & Jerskey, 2015; LoParo & 
Waldman, 2015). It is also associated with childhood social problems and quality of pair-
bonding in women (Walum et al., 2012). 
Because the G allele is associated with autism spectrum disorder and more 
disrupted social efficacy, this is considered the lower social responsiveness allele 
(Campbell et al., 2011). Although the functional significance of this SNP has not been 
established, the G allele’s location in the OXTR promotor region may inhibit transcription 





The A allele of rs2268493 is associated with poorer performance on social 
cognition and social perception in participants with schizophrenia (M. C. Davis et al., 
2014). The children with A/A genotype may also be more resistant to social pressures 
that inhibit progress in group interventions for externalizing problems (Glenn et al., 
2018). This allele is also associated with autism spectrum disorder (Di Napoli, Warrier, 
Baron-Cohen, & Chakrabarti, 2014) and decreased brain response to reward (Damiano et 
al., 2014). The A allele is of rs2268493 is considered the lower oxytocin 
neurotransmission allele. Although functional effects are unclear, this allele is associated 
with higher amygdala activity, which is indicative of lower oxytocin neurotransmission 
(Kirsch, 2015).  
OXTR rs237885 
The T allele of rs237885 is associated with callous unemotional traits that reflect 
less sensitivity toward others and diminished empathic response (Beitchman et al., 2012). 
This allele is also associated with certain traits of depression, such as startle reflex 
(Comasco et al., 2016). The T allele of rs237885 is associated with less empathic 
response (Beitchman et al., 2012), autism spectrum disorder, and increased amygdala 
activity associated with lower oxytocin neurotransmission (Bartholomeusz, Ganella, 
Labuschagne, Bousman, & Pantelis, 2015). Thus, the T allele is considered the lower 
oxytocin neurotransmission allele.  
OXTR rs2254298 
The G allele of rs2254298 is associated with lower plasma oxytocin levels and 
related behavioral phenotypes such as reduced parental touch (Feldman et al., 2012). This 
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allele has also been associated with empathy, autism spectrum disorder, and depression 
(Costa et al., 2009). Because the G allele confers lower oxytocin and higher risk for 
social issues, this allele is considered the lower oxytocin neurotransmission allele 
(Feldman et al., 2012). 
CD38 rs3796863 
The C allele of rs3796863 is associated behavioral phenotypes such as reduced 
parental touch (Feldman et al., 2012). Additionally, people with the A allele report 
stronger empathic responses and more willingness to donate when told a teacher in their 
university cannot afford medical treatment (Liu, Gong, Li, & Zhou, 2017). The C allele is 
associated with lower plasma oxytocin levels, which are correlated with levels in the 
brain and likely indicate lower oxytocin neurotransmission (Feldman et al., 2012). Thus, 
the C allele is considered the lower oxytocin neurotransmission allele. 
OXT rs2740210 
Genetic variation in rs2740210 has been associated with postpartum depression 
(Jonas et al., 2013) and moderates effects of some social experiences. Maternal verbally 
aggressive behavior was associated with general anxiety at age 5-6 and emotional 
symptoms at age 11-12 only for children with the C/C genotype of rs2740210 (Smarius et 
al., 2020). However, this genotype did not moderate the association between maternal 
verbal aggression and blood pressure in 5-6 year old children (Smarius et al., 2019). The 
association between social support and psychiatric distress is also only present for G 
allele carriers (Love et al., 2018). There is also evidence that depression mediates 
associations between early life adversity and breastfeeding only for women with the C/C 
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genotype (Jonas et al., 2013). Although functional effects of this SNP have not been 
established and there is no evidence for regulation in neural tissue 
(www.RegulomeDB.org), correlations of the C allele with increased responsiveness and 
breastfeeding are consistent with this allele conferring higher oxytocin neurotransmission 
(Jonas et al., 2013). 
Oxytocin and Social Responsiveness 
 Oxytocin neurotransmission is associated with a wide array of social behaviors 
such as pair bonding, affection, and cooperation (Ebstein, Israel, Chew, Zhong, & Knafo, 
2010). Genetic variation in the oxytocin system has been associated with trait-level 
differences in social processing abilities and social behavioral tendencies, so because of 
the aforementioned likely role of genetic variation in this system in oxytocin 
neurotransmission, it may modulate how individuals perceive and respond to their social 
environment. Although the associations between oxytocin neurotransmission and plasma 
oxytocin levels are not well-understood, oxytocin-related genetic variation is associated 
with levels in the plasma and relevant brain regions, and has similar associations with 
behavior as intranasal oxytocin administration (Neumann et al., 2013). 
 Genetic variation in the oxytocin system such as rs53576 is associated with traits 
related to social responsiveness including empathy and stress reactivity (Rodrigues, 
Saslow, Garcia, John, & Keltner, 2009). OXT rs4813625 is associated with differential 
susceptibility to parenting style in association with social anxiety (increasing risk of 
social anxiety in context of maladaptive parenting, but decreasing risk of social anxiety in 
context of warm and supportive parenting), whereas OXT rs2770378 is associated with 
diathesis-stress (increasing risk of social anxiety in context of maladaptive parenting, but 
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having no association with social anxiety in context of warm and supportive parenting; 
Olofsdotter, Åslund, Furmark, Comasco, & Nilsson, 2018). There is also evidence that 
OXTR rs2254298 is associated with sociability, amygdala volume, autism, depression, 
and anxiety dependent on early environmental experiences, which may support a 
differential susceptibility framework for understanding effects of this polymorphism 
(Brüne, 2012). 
Prosocial Theory 
Several theories differ in their explanations of the mechanism by which oxytocin 
levels might impact social behaviors. The Prosocial Theory focuses on oxytocin’s role in 
promoting social bonds, which is consistent with oxytocin’s long-known role in 
stimulating maternal care (D. D. Francis, Young, Meaney, & Insel, 2002) and pair-
bonding (Walum et al., 2012). Associations between increased oxytocin and trust 
(Kosfeld et al., 2005), affection (Kortesluoma & Karlsson, 2011), and other prosocial 
behaviors also support the Prosocial Theory; however, evidence that oxytocin can also be 
associated with aggression and ethnocentrism (Bosch et al., 2005; De Dreu et al., 2011) 
show that oxytocin is not associated with exclusively prosocial behavior in all contexts, 
thus leading to two more modern theories that describe other possible mechanisms for 
oxytocin’s role in social behavior.  
Social Salience Theory  
The Social Salience Theory focuses on the alternate explanation that oxytocin 
increases salience to social stimuli, thus explaining aggressive behaviors when that 
specific social stimuli elicits negative reactions (Shamay-Tsoory & Abu-Akel, 2016). 
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Administering intranasal oxytocin selectively improves attention and memory for faces, 
but not non-social stimuli (Rimmele, Hediger, Heinrichs, & Klaver, 2009).  
Social Approach Theory 
The Social Approach Theory also explains both prosocial and antisocial behaviors 
associated with oxytocin by positing that oxytocin increases the tendency to engage 
socially, whether in a prosocial or antisocial manner (Shamay-Tsoory, 2010). Proponents 
of this theory note that administering oxytocin increases some approach behaviors that 
are likely unrelated to attention, such as women receiving intranasal oxytocin 
approaching male researchers at a quicker pace and more proximately (Preckel, Scheele, 
Kendrick, Maier, & Hurlemann, 2014).  
Comparing Theories 
Although the Social Salience Theory and Social Approach Theory are both 
consistent with most known correlates of oxytocin neurotransmission, the way individual 
differences in the oxytocin system may be connected to social support would likely differ 
between the theories. The unanswered distinction between the Social Salience and Social 
Approach theories will be tested by model comparisons in the proposed study.  
People with higher levels of oxytocin neurotransmission might benefit more from 
social support because of increased salience to their nurturing social environment, as the 
Social Salience Theory would predict. Based on the Social Salience Theory, associations 
between social experiences and outcomes may be stronger for people with more oxytocin 
neurotransmission. Social Salience theory would predict that people with more oxytocin 
neurotransmission have higher social salience, thus are more responsive to social support 
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they experience. Thus, based on the Social Salience theory, genetic variation in the 
oxytocin system should moderate the association between social network size and 
perceived social support, or thus moderate the indirect effect of social network size on 
depression symptoms through perceived social support (see Figure 4.1, Part A) 
The Social Approach theory, however, would explain the increased benefits for 
people with increased oxytocin neurotransmission based on their likely increased social 
interactions. Based on the Social Approach theory, people with more oxytocin 
neurotransmission have a stronger tendency to seek social support; thus, they receive 
more, explaining any associated beneficial outcomes. This increased social support might 
be a mechanism for decreased depression symptoms in people with more oxytocin 
neurotransmission. Based on this theory, genetic variation associated with increased 
oxytocin neurotransmission would be associated with a larger social network size, which 
would be associated with higher perceived social support, and therefore lower depression 
symptoms. In other words, the Social Approach Theory model would show an indirect 
effect of oxytocin-related genetic variation on depression symptoms through social 
network size and perceived social support (see Figure 4.1, Part B). 
Current Study 
The current study uses a polygenic approach to test for an association between 
genetic variation in the oxytocin system and depression symptom severity and whether 
this polygenic score moderates associations between social experiences and depression 
symptom severity. We also test associations between the polygenic score and social 
responsiveness traits, including alexithymia, rejection sensitivity, need to belong, self-
monitoring, dispositional empathy, and a Social Responsiveness latent variable. This 
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study also tests whether genetic variation in the oxytocin system fits better in a model 
consistent with the Social Approach Theory or Social Salience Theory (Figure 4.1 depicts 
the models that will be compared), addressing current debates about which theory better 
explains the role of the oxytocin system in social behavior.  
A. Social Salience Theory Model 
B. Social Approach Theory Model 
Figure 4.1. Social Theories of Oxytocin. A model comparison between A. a model 
testing the Social Salience Theory and B. a model testing the Social Approach Theory of 
oxytocin will provide evidence regarding the potential role of oxytocin-related genetic 
variation in association with social support and depression symptoms. 
 
Methods 
Undergraduate research participants were recruited from a research pool at the 
University of Nebraska-Lincoln and received course credit for participation. A total of 
1,128 participants provided informed consent, completed computerized surveys and 
donated buccal cells. Genotypes for all SNPs in the polygenic score were obtained for 
1,022 participants by extracting DNA from buccal cells and genotyping for each SNP 
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using real-time polymerase chain reaction. Participants with missing genotypes for any of 
the SNPs did not receive a polygenic score. 
Measures 
The Beck Depression Inventory (BDI; Beck, Steer, & Brown, 1996) was used to 
measure depression symptom severity. It is widely used and has high test-retest reliability 
(r = 0.93; Beck, Steer, & Brown, 1996) and high internal consistency (Alpha = 0.91; 
Beck, Steer, Ball, et al., 1996). Participants responded to 21 multiple choice items 
indicating the intensity of depression symptoms within the past 2 weeks (e.g. “I am not 
particularly discouraged about the future,” “I feel discouraged about the future,” “I have 
nothing to look forward to”, or “I feel the future is hopeless and that things cannot 
improve”). Scores are summed, ranging from 0 to 63, with higher scores indicating 
higher depression symptom severity. Cronbach’s alpha for the current sample was .92. 
Perceived social support was measured using the Multidimensional Scale of 
Perceived Social Support (MSPSS; Zimet, Dahlem, Zimet, & Farley, 1988). Participants 
rated 12 items on a scale from 1 (very strongly disagree) to 7 (very strongly agree) 
regarding relationships with a significant other, family, and friends (e.g. “There is a 
special person with whom I can share my joys and sorrows”). This scale demonstrates 
acceptable internal reliability (Cronbach’s alpha for current sample = .77) and has good 
test-retest reliability (alpha = .85). 
Social network size was measured using the Social Network Index (Cohen, 
Doyle, Skoner, Rabin, & Gwaltney, 1997). This instrument includes 12 multiple-choice 
items regarding the number of people in participants’ social network (e.g. “How many 
other relatives [other than your spouse, parents & children] do you feel close to?” with 
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response options 0-6 or “7 or more.”) Each item also has a follow-up to assess the 
involvement of the social network members in participants’ lives (e.g. “How many of 
these relatives do you see or talk to on the phone at least once every 2 weeks?”, with 
response options 0-6 or “7 or more”). 
Childhood trauma was measured with the Childhood Trauma Questionnaire 
(Pennebaker & Susman, 2013), which asks participants about six potential traumatic 
experiences prior to age 17, including death of a close friend or family member, upheaval 
between parents, traumatic sexual experience, violence, severe illness or injury, and other 
major upheaval. For each item, participants indicated whether they had experienced it, 
and if yes rated how traumatic it was on a scale of 1 (not at all traumatic) to 7 (extremely 
traumatic). A composite score of the “how traumatic” responses for all items the 
participant experienced yielded the childhood trauma score, with scores ranging from 0 
(reported not experiencing any of the 6 items) to 42 (indicated experiencing all items as 
extremely traumatic). 
Perceived discrimination was measured with the Perceived Discrimination Scale 
(Williams, Yu, Jackson, & Anderson, 1997). This 20-item scale includes 11 items for 
participants to indicate how many times they have experienced discrimination during 
their lifetimes (e.g. You were discouraged by a teacher or advisor from seeking higher 
education”) and 9 items that ask participants to respond on a scale from 1 (often) to 4 
(never) regarding general unfair treatment (e.g. You are treated with less courtesy than 
other people”). All items are reverse coded and summed to represent scores for perceived 
discrimination. Cronbach’s alpha for the current sample was .85. 
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Sexual objectification was measured using the Interpersonal Sexual 
Objectification Scale (ISOS; Kozee et al., 2007). Participants rated the frequency with 
which they have experienced 15 items on a scale from 1 (never) to 5 (almost always) in 
the past year. Sample items include: “How often have you been whistled at while walking 
down a street?” and “How often have you been touched or fondled against your will?” 
Mean scores were calculated with higher scores representing greater levels of sexual 
objectification. The ISOS has been structurally validated with exploratory and 
confirmatory factor analysis (Kozee et al., 2007). Previous psychometrics report internal 
consistency of .92 and test-retest reliability of .90. Cronbach’s alpha for the current 
sample was .94. 
The need to belong is the intensity of a person’s desire for acceptance and 
belonging. It is associated with higher risk of depression symptom severity; however, this 
association is buffered by the presence of more fully-satisfying relationships (Pillow, 
Malone, & Hale, 2015). The Need to Belong scale (Leary, Kelly, Cottrell, & 
Schreindorfer, 2013) contains 10 items (e.g. I try hard not to do things that will make 
other people avoid or reject me”) on which participants indicated their agreement from 0 
(strongly disagree) to 4 (strongly agree). It has acceptable interitem reliability 
(Cronbach’s alpha for the current sample = .75) and test-retest reliability of .87. 
Rejection sensitivity measures likelihood of expecting and being concerned by the 
potential of social rejection and is positively correlated with depression (Gao, Assink, 
Cipriani, & Lin, 2017). It moderates the impact of acute experiences of rejection on self-
concept, which may partially explain the mechanism of its connection with depression 
symptom severity (Ayduk, Gyurak, & Luerssen, 2009). The Rejection Sensitivity 
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Questionnaire (RSQ), examines situations involving potential rejection. The participant 
indicates their concern about a situation’s outcome on a scale from 1 (very unconcerned) 
to 6 (very concerned), and then indicates the likelihood that the other individual would 
respond preferably on a scale from 1 (very unlikely) to 6 (very likely). Scores from 18 
items range from 1 to 36, with higher scores indicating higher rejection sensitivity 
(Downey & Feldman, 1996). An expectancy-value model (Bandura, 1986) was used to 
calculate RSQ scores by reverse scoring the expectancy of a positive outcome and 
multiplying it by the score of concern for each item, then calculating an average across 
items. Cronbach’s alpha for the current sample was .91. 
Alexithymia is a stable, continuous trait representing difficulty identifying, 
processing, and verbalizing emotions in oneself and others (Martínez-Sánchez, Ato-
García, & Ortiz-Soria, 2003). Higher alexithymia is associated with depression and 
anxiety (Marchesi, Brusamonti, & Maggini, 2000); however, this trait also interacts with 
experience in association with depression symptom severity. In Japanese workers, the 
association between social support and lower depression severity was only present for 
low alexithymia individuals (Kojima, Senda, Nagaya, Tokudome, & Furukawa, 2003). 
Alexithymia was assessed using the Online Alexithymia Questionnaire-G2 (OAQ-G2). 
This scale includes 37 items rated on a scale of 1 (strongly disagree) to 5 (strongly agree), 
with higher scores indicating more alexithymia (Thompson, 2008). Cronbach’s alpha for 
the current sample was .88. 
Dispositional empathy is one’s tendency to share in the emotions of others. Lower 
empathy is associated with higher depression symptom severity via unforgiving 
temperament (Burnette, Davis, Green, Worthington Jr, & Bradfield, 2009). Although 
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lower empathy is typically associated with higher depression symptom severity, (Bennik, 
Jeronimus, & Aan Het Rot, 2019), high empathy can also be a risk factor for depression 
for people with certain traits, including poor emotion regulation (Tully, Ames, Garcia, & 
Donohue, 2016). Dispositional empathy was assessed with the Interpersonal Reactivity 
Index (Carey, Fox, & Spraggins, 1988). This measure includes 28 items which 
participants rate from 1 (“Does not describe me well”) to 5 (“Describes me very well”). 
Scores on items (e.g. “I often have tender, concerned feelings for people less fortunate 
than me”) are aggregated. Internal consistency is adequate with Cronbach’s alpha of .85 
for the current sample.  Test-retest reliability is also adequate, ranging from .61-.81 
(Davis, 1980).  
Self-monitoring is a person’s tendency to closely attend to the social environment 
and modulate their behavior based on that context. People high in self-monitoring have 
lower autonomic and cortical arousal in anticipation of social threat compared to people 
with low self-monitoring (Hofmann, 2006). Although self-monitoring is usually 
associated with higher social abilities that may be protective against depression, and self-
monitoring techniques focused on positive experiences can be used to reduce depression 
symptom severity (Kauer et al., 2012), higher self-monitoring is also associated with 
some risk. Higher self-monitoring is associated with substance use, which can also be 
associated with depression, and when impression management attempts are perceived as 
unsuccessful, the self-monitoring process can lead to higher anxiety and lower self-
esteem (Sharp & Getz, 1996). Self-monitoring was measured with the Self-Monitoring 
Scale (SMS; Snyder, 1974) which includes 25 items (e.g.“When I am uncertain how to 
act in a social situation, I look to the behavior of others for cues”) to which participants 
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respond true or false. A sum score of items answered with the “high self-monitoring” 
response option was calculated. Cronbach’s alpha for the current sample was .72. 
Oxytocin System Polygenic Score 
DNA extracted from buccal samples for each participant was genotyped for 10 
single nucleotide polymporphisms (SNPs) in the oxytocin system to create a polygenic 
score of oxytocinergic neurotransmission. This approach involves selecting several 
variants within a biological system and aggregating them (Bogdan, Pagliaccio, Baranger, 
& Hariri, 2015). SNPs were selected using NCBI Variant Viewer to screen for SNPs in 
oxytocin receptor gene, oxytocin gene, and CD38 (LNPEP was excluded based on lack of 
evidence for its association with behavioral phenotypes). Screening for SNPs with 
publications and minor allele frequency (MAF) greater than .05 yielded 49 SNPs in the 
oxytocin receptor gene, 9 in the oxytocin gene, and 11 in CD38 in dbSNP. Previous 
studies assessing associations between these variants and traits relevant to social 
responsiveness and depression were reviewed, and the 10 with the strongest evidence 
were selected (see Chapter 3). The polygenic score created from these SNPs indicates 
additive associations with oxytocin neurotransmission. For each SNP, the genotype 
associated with highest oxytocin neurotransmission is scored as 2, and lowest is scored as 
0, with heterozygotes scored as 1. Thus, polygenic scores range from zero (genetic 
variation associated with lowest oxytocin neurotransmission) to 20 (genetic variation 
associated with highest oxytocin neurotransmission). Only participants with genotypes 
for all SNPs were given a polygenic score. Table 4.1 contains information about each 




Table 4.1: Oxytocin-related SNPs used in polygenic score 





rs53576 OXTR  chr3:8762685 
(GRCh38.p12) 




rs2254298 OXTR chr3:8760542 
(GRCh38.p12) 




rs1042778 OXTR chr3:8752859 
(GRCh38.p12) 




rs237887 OXTR chr3:8755356 
(GRCh38.p12) 




rs7632287 OXTR chr3:8749760 
(GRCh38.p12) 




rs2268493 OXTR chr3:8759154 
(GRCh38.p12) 




rs2268498 OXTR chr3:8770725 
(GRCh38.p12) 




rs3796863 CD38 chr4:15848363 
(GRCh38.p12) 




rs237885 OXTR chr3:8753857 
(GRCh38.p12) 




rs2740210 OXT chr20:3072609 
(GRCh38.p12) 




Data Analytic Methods 
 Statistical analyses were conducted with MPlus software (Muthén & Muthén, 
2010) using MLR. To reduce risk of false positives due to multiple testing, a Bonferroni 
correction was used to control the familywise error rate for the 41 estimates used to test 
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hypotheses. All results are considered in context of the corrected p value of .001 as a 
threshold for significance. 
A regression was used to test whether polygenic scores were associated with 
depression symptom severity, alexithymia, dispositional empathy, self-monitoring, need 
to belong, or rejection sensitivity when controlling for gender, age, race, ethnicity, and 
sexual orientation as covariates (see Figure 4.2 A). Association between the polygenic 
score and a latent Social Responsiveness construct including dispositional empathy, self-
monitoring, need to belong, and rejection sensitivity as indicators was also tested (See 
Figure 4.2 B).  
Figure 4.2. Associations with oxytocin system polygenic score. A. The polygenic score 
of oxytocin-related variants was tested in association with rejection sensitivity, need to 
belong, dispositional empathy, self-monitoring, alexithymia, and depression symptom 
severity using age, race, ethnicity, gender, and sexual orientation as covariates. B. A 
latent variable of Social Responsiveness was created using rejection sensitivity, need to 
belong, self-monitoring, and dispositional empathy as indicators (alexithymia was 
excluded due to lack of bivariate correlations with other indicators as well as poor fit in 
the CFA). This latent variable was tested in association with the polygenic score. 
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A moderation model tested whether polygenic score moderated associations from 
perceived social support, perceived discrimination, childhood trauma, or sexual 
objectification to depression symptom severity (See Figure 4.3 A). An additional 
moderation model was tested using a net social experience score aggregating Z scores of 
perceived social support, perceived discrimination, childhood trauma, and sexual 
objectification to test if polygenic score moderated the association between this overall 
score of social experiences and depression symptom severity (Figure 4.3 B). This 
formative construct was created, as opposed to a reflexive latent variable such as that 
created for Social Responsiveness, because it was hypothesized that the cumulative effect 
of several social experiences captured the relevant range of overall social experiences 
better than the shared variance among the social experiences (as they are all distinct 
experiences that may not be associated with one another). Both moderation models 




Figure 4.3. Testing for moderation of an association between social experiences and 
depression symptom severity by the polygenic score of genetic variation in OXT 
system. Part A shows the model tested to test if the polygenic score moderates 
associations between any of the individual social experiences measured and depression 
symptom severity. Part B shows the model tested using an aggregate of Z scores of 
perceived social support, childhood trauma, perceived discrimination, and sexual 
objectification to create the Net Social Experiences score. Both models included age, 
race, ethnicity, gender, and sexual orientation as covariates. 
To test whether Social Salience theory or Social Approach theory better explain 
connections between social support and depression symptoms, a model comparison 
approach was used to test associations among the polygenic score for oxytocinergic 
neurotransmission, depression symptoms, and social support and social network size. 
Two models including the same variables represent the predictions of each theory, and a 
model comparison was used to planned to examine which has better fit, therefore 





Univariate statistics are shown in Table 4.2. These descriptive statistics align with 
those expected of a midwestern United States college student sample (Luster-Edward & 
Martin, 2019). Demographics are representative of the university where the sample was 
obtained (Data Index). Continuous variables were relatively normally distributed, and 
robust maximum likelihood estimation (MLR) was used for multivariate analyses to avoid 
bias due to univariate and multivariate non-normality in hypothesis testing. Bivariate 
correlations are shown in Table 4.3 (correlations not shown in this table can be found in 
Table 2.2). None of the correlations exceeded r = .7, so no variables were excluded from 




Table 4.2: Univariate Statistics 
Gender (N = 1,123) Man n = 316 (28.10%) 
Woman n = 807 (71.54%) 
Sexual Orientation (N = 1,128) Straight n = 1014 (89.89%) 
Gay/Lesbian n = 24 (2.13%) 
Bisexual n = 67 (5.94%) 
Pansexual n = 15 (1.33%) 
Asexual n = 4 (0.35%) 
Other n = 4 (0.35%) 
Race (N = 1,095) White n = 877 (77.75%) 
Black n = 55 (4.88%) 
Chinese n = 44 (3.90%) 
Vietnamese n = 33 (2.93%) 
Japanese n = 1 (0.09%) 
Asian Indian n = 15 (1.33%) 
Other Asian racial identity n = 23 (2.04%) 
Native American n = 9 (0.80%) 
Pacific Islander n = 3 (0.37%) 
Race not captured by 
survey options 
n = 35 (3.10%) 
Hispanic/ Latinx (N = 1,124) Hispanic n = 100 (8.87%) 
Not Hispanic n = 1024 (90.78%) 
Age (N = 1,122) M = 20.34, SD = 2.60 
Need to Belong (N = 1,125) M = 34.51, SD = 5.99 
Rejection Sensitivity (N = 1,128) M = 7.19, SD = 2.96 
Self-monitoring (N = 1,128) M = 12.69, SD = 3.80 
Alexithymia (N = 1,093) M = 95.26, SD = 16.44 
Dispositional Empathy (N = 1,128) M = 3.11, SD = 0.31 
Perceived Social Support (N = 1,128) M = 5.43, SD = 0.88 
Perceived Discrimination (N = 1,109) M = 12.16, SD = 7.77 
Sexual Objectification (N = 1,128) M = 1.93, SD = 0.68 
Childhood Trauma (N = 1,128) M = 6.99, SD = 6.21 
Social Network Size (N = 1,128) M = 18.00, SD = 8.18 
Polygenic Score (N = 1,022) M = 10.29, SD = 1.85 
Depression Symptom Severity (N = 
1,123) 





Table 4.3: Bivariate Correlations 
 
Polygenic Score Social Network Size 
Polygenic Score 1 
 
Social Network Size 0.024 1 
Gender 0.017 -0.08* 
Age 0.058 -0.038 
Sexual orientation 0.013 -0.109** 
Hispanic -0.069* -0.078* 
Race -0.072* -0.127* 
Need to belong -0.028 0.07 
Rejection sensitivity -0.024 -0.25** 
Self-monitoring -0.003 0.067* 
Alexithymia -0.01 -0.192** 
Dispositional empathy -0.001 -0.018 
Perceived social support 0.018 0.237** 
Childhood trauma 0.033 -0.005 
Discrimination -0.001 -0.113** 
Sexual objectification 0.073* 0.087* 
Depression symptom severity -0.031 -0.267** 
Net social experience score -0.035 0.107** 
* = p < .05, ** = p < .001. The following variables are coded as binary: Gender (woman = 0, 
man = 1), sexual orientation (0= heterosexual, 1 = sexual minority), Hispanic (0 = not 
Hispanic, 1 = Hispanic), race (0 = White, 1 = racial minority). 
 
Because 8 of the 10 selected SNPs were on the OXT gene, Haploview was used to 
test for linkage disequilibrium. Based on the most commonly-used threshold of r2 > .8 to 
determine if any of the SNPs are in strong linkage disequilibrium, all 10 SNPs were 
sufficiently independent to include in the polygenic score (Carlson et al., 2004; see 
Figure 4.4). Three of the 10 SNPs were not in Hardy-Weinberg equilibrium using a p > 
.05 threshold (see Table 4.4); however, this is likely due to the large sample size, because 
chi-square tests are often significant in large samples (Berkson, 1938). A separate 
polygenic score was created excluding the SNPs with questionable Hardy-Weinberg 
equilibrium in case they were unreliable; none of the results differed using this alternative 
score. Genotyping reliability was verified by redoing genotyping on a randomly-selected 
10% of the samples, which resulted in an error rate of less than 0.2%. Out of the 1,128 
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participants genotyped, there were 106 participants missing genotypes for one or more of 
the 10 SNPs. Polygenic scores were calculated for the 1,022 participants with genotypes 
for all SNPs by summing the scores for each SNP using the coding indicated in Table 4.1. 
 
Figure 4.4: Haploview Plot of R2 Values for SNPs in OXTR. A test of linkage 
disequilibrium for the 8 SNPs on the OXT gene was conducted using Haploview. None of 
the r2 values surpassed the threshold of .8 that would have suggested strong linkage 




















rs53576 n = 160 n = 486 n = 454 0.37 2.575 0.28 
rs237887 n = 381 n = 523 n = 204 0.42 1.081 0.58 
rs1042778 n = 172 n = 476 n = 446 0.37 5.602 0.061 
rs2254298 n = 29 n = 247 n = 822 0.14 3.893 0.143 
rs2268498 n = 207 n = 532 n = 360 0.43 0.178 0.915 
rs2268493 n = 585 n = 410 n = 110 0.29 8.893 0.012* 
rs3796863 n = 495 n = 452 n = 144 0.34 6.258 0.044* 
rs2740210 n = 103 n = 481 n = 511 0.31 0.446 0.8 
rs237885 n = 244 n = 533 n = 291 0.48 < 0.001 >.999 
rs7632287 n = 674 n = 365 n = 55 0.22 0.375 0.829 
* = significant chi square indicates that rs2268493 and rs3796863 are not in Hardy-
Weinberg equilibrium with a p < .05 significance threshold. For both SNPs, there are 
more homozygotes and fewer heterozygotes than would be expected. 
 
There was no statistically significant bivariate correlation between the polygenic 
score and depression symptom severity or any of the social responsiveness traits. There 
were still no statistically significant associations with the polygenic score when 
controlling for gender, age, race, Hispanic identity, and sexual orientation. When 
controlling for covariates, the association of the polygenic score with depression 
symptom severity was b = 0.07, p = .64. When controlling for covariates, the association 
of the polygenic score with rejection sensitivity was b = -0.03, p = .56, the association 
with dispositional empathy was b = -.001, p = .92, the association with alexithymia was 
b = 0.03, p = .93, and the association with self-monitoring was b = -.003, p = .95.  
We conducted a confirmatory factor analysis for a latent variable of Social 
Responsiveness connecting need to belong, rejection sensitivity, self-monitoring, and 
dispositional empathy. Because alexithymia was not statistically significantly associated 
with need to belong, dispositional empathy, or self-monitoring, it was not included. The 
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global fit was adequate, as indicated by CFI = .98, TLI = .93, RMSEA = 0.04, 90% CI 
[0.01, 0.52], SRMR = 0.02. The chi-square value was 6.40, p = .04. The standardized 
coefficients for all indicators were significant and sufficiently large (rejection sensitivity 
B = .36, p < .001; need to belong, B = .58, p < .001; dispositional empathy, B = .43, p < 
.001; self-monitoring, B = .34, p < .001). Rejection sensitivity was the scaling indicator. 
Next, we tested the hypothesized model with the polygenic score predicting the latent 
variable of Social Responsiveness. Global fit was adequate, CFI = .991, TLI = .982, 
RMSEA = .965, SRMR = .015. The association between the polygenic score and the 
Social Responsiveness latent variable was not significant using the corrected p value 
threshold of .001, b = -.022, p = .41. 
The polygenic score did not moderate paths from perceived social support (b = 
0.23, p = .11), perceived discrimination (b = -0.02, p =.23), childhood trauma (b = -0.05, 
p = .06), or sexual objectification (b = 0.18, p = .45) to depression symptom severity. We 
created a composite score of social experiences, a formative construct, by aggregating Z 
scores of perceived social support, perceived discrimination, childhood trauma, and 
sexual objectification. The polygenic score did moderate the association between this 
composite score of general social experiences and depression symptom severity (b = 
0.15, p = 0.01). However, this effect did not remain statistically significant after 
correction for multiple testing. 
The polygenic score also played no statistically significant role in either of the 
models connecting social network size, perceived social support, and depression 
symptom severity. In the model based on social approach theory, social network size was 
directly inversely associated with depression symptom severity (b = -1.71, p < .001) and 
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was mediated by perceived social support (for path from social network size to social 
support, b = 0.18, p < .001; for path from perceived social support to depression 
symptom severity, b = -2.45, p < .001). However, the association between the polygenic 
score and social network size was not statistically significant (b = -0.03, p = .32). The 
polygenic score also did not significantly contribute to variation in perceived social 
support (b = 0.02, p = .53) or depression symptom severity (b = 0.09, p = .71). In the 
model based on social salience theory, the direct effect of social network size on 
depression symptom severity remained significant (b = -3.08, p = .02), but only before 
correction for multiple testing. Perceived social support was still associated with 
depression symptom severity in this model (b = -2.45, p < .001); however, social 
network size was no longer associated with perceived social support (b = 0.11, p = .41) 
when not accounting for the contribution of covariates to variation in social network size. 
The polygenic score did not moderate the association between social network size and 
perceived social support (b = 0.11, p = .41) or the association between social network 
size and depression symptom severity (b = 0.02, p = .29).  
Discussion 
Using a polygenic score created from 10 SNPs in the oxytocin system with the 
strongest prior evidence of associations with depression and social responsiveness, this 
study found no evidence that this polygenic score is associated with depression symptom 
severity or any of the social responsiveness traits measured. The polygenic score also 
played no role in a model connecting social network size, perceived social support, and 
depression symptom severity. Even using an abundance of previous evidence to select the 
most likely genetic variants in the oxytocin system to be associated with social 
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responsiveness, this approach yielded no evidence of the hypothesized associations. This 
adds to previous studies using large sample sizes and strong methodology that show no 
associations between genetic variation in the oxytocin and complex behavioral outcomes 
such as depression symptoms, and is consistent with the frequency of replication failures 
in behavior genetics research (Gorroochurn, Hodge, Heiman, Durner, & Greenberg, 
2007). 
The polygenic score did moderate an association between the formative score of 
social experiences and depression symptom severity (b = 0.15, p = 0.01). This suggests 
that the association between social experiences and depression symptom severity is 
stronger for people with a polygenic score indicating higher oxytocin neurotransmission. 
However, this effect was not robust to correction for multiple testing, and the polygenic 
score did not moderate paths from perceived social support (b = 0.23, p = .11), perceived 
discrimination (b = -0.02, p =.23), childhood trauma (b = -0.05, p =.06), or sexual 
objectification (b = 0.18, p = .45) to depression symptom severity. Considering the small 
effect size, not surviving correction for multiple testing, and the fact that the moderation 
was not present when the social experiences were investigated individually, this effect is 
interpreted with caution and the understanding that it may be spurious. 
Strengths and Limitations 
This study aligned with current efforts away from binary diagnostic outcomes by 
using a dimensional measure of depression symptom severity; this strength in depression 
measurement in this study could be extended further in the future by separating different 
depression symptoms, in line with movements toward approaches such as the 
Hierarchical Taxonomy of Psychopathology (HiTOP) for psychiatric genetics (Kotov et 
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al., 2021). The use of a large sample size and a polygenic score including 10 SNPs 
provides stronger evidence than most studies investigating associations between genetic 
variation in the oxytocin system and depression (Chapter 3). This study filled a necessary 
gap in testing this association in context of several different social experiences including 
positive (social support) and negative (discrimination, childhood trauma, sexual 
objectification) experiences and testing for associations with a variety of social 
responsiveness traits. 
The implications of the genetic associations tested in this study must not be over-
stated. Although there are benefits to making hypothesis-driven, biologically-informed 
approaches in genetics research to assess the possible role of a biological system of 
interest, independent replication is vital for verifying results, particularly in genetic 
studies with small effect sizes. Only 27% of replication studies confirm previous gene-
by-environment interactions (Duncan & Keller, 2011). Genetic effects are often small 
and context dependent, and even aggregating several variants within a system may fail to 
create a polygenic score strong enough to detect an effect. Without full understanding of 
the functional effects of each SNP in the polygenic score, the biological consequences of 
differing polygenic score scores are also not entirely known. The r2 threshold used for 
inclusion of SNPs may underestimate linkage disequilibrium due to its accounting of 
allele frequency, and based on the high correlation between a couple individual SNP 
genotypes (r = .82 between rs237887 and rs237885), these SNPs may have been 
somewhat redundant, resulting in a disproportionate influence on the polygenic score. It 
is also possible, especially considering the unclear functional evidence of the SNPs, that 
the coding of one or more SNPs in the polygenic score could have been reversed; 
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however, inspection of the bivariate correlations with individual SNPs did not reveal any 
consistent or strong associations in the opposite direction of hypotheses. Results did not 
differ based on removing one of the SNPs with the highest correlation. Genetic effects in 
this study were consistently miniscule and not statistically significant despite the large 
sample size, yielding strong evidence that this genetic variation was not an important 
factor in depression symptom severity or social responsiveness. 
The scope of this study is reasonably narrow, so many of the limitations could be 
addressed using a broader lens. Considering self-determination theory (Ryan & Deci, 
2000) which underlines the human need for competence, autonomy, and relatedness, it 
may be important to ensure measures are included to assess how social relationships may 
be meeting, but also interfering with these needs (Ibarra-Rovillard & Kuiper, 2011).  To 
fully assess this, measures that capture social conflict, hostility, over-controlling behavior 
and criticism should be included in addition to perceived social support and social 
network size (McCleary & Sanford, 2002). Future research should test for associations 
between social network size, perceived social support, and Basic Need Satisfaction in 
Relationships (La Guardia, Ryan, Couchman, & Deci, 2000) to further clarify what 
aspects of social support are most closely related to depression symptoms and how 
various aspects of social support can be differentially modulated by individual 
differences. A future study would also include questions about major life events to (e.g. 
marriage, divorce, deaths of loved ones, etc.) to assess other variables that are likely to be 
associated (Girz, Driver‐Linn, Miller, & Deldin, 2017). 
Several other traits associated with resilience are notably missing from the current 
study, which may be added to future studies including optimism (perhaps measured with 
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LOT-R; Scheier, Carver, & Bridges, 1994), Cognitive Flexibility (Martin & Rubin, 
1995), and emotion regulation (measured with Difficulties in Emotion Regulation Scale; 
Gratz & Roemer, 2004; Southwick & Charney, 2012). Positive and negative social 
experiences, resilience traits, and depression are all closely associated with anxiety and 
other facets of well-being as well, so future research should also include a measure of 
stress and anxiety (Depression Anxiety Stress Scales; Lovibond & Lovibond, 1995) and 
general well-being (using the Warwick-Edinburgh mental well-being scale, WEMWBS; 
Gratz & Roemer, 2004) to assess a more comprehensive model of social responsiveness 
and well-being. 
Conclusions 
This study found no evidence for an association between genetic variation in the 
oxytocin system and depression symptom severity, even when considering the context of 
social experiences. Genetic variation in the oxytocin system was not strongly associated 
with any of the social responsiveness traits measured.  
Further investigation of how genetic variation is associated with individual 
differences in depression symptom etiology is still valuable to help guide pursuit of more 
individualized approaches to mental health by elucidating how biological factors and 
experiences interact to predict depression symptoms. Although current depression 
treatments do not target the oxytocin system, there is evidence that oxytocin may be part 
of a useful treatment approach for some people struggling with depression and social 
attachment issues (Slattery & Neumann, 2010). Administering oxytocin to depressed 
males before therapy sessions has shown some potential benefits, but evidence is still 
preliminary (MacDonald et al., 2013). Current efforts in precision medicine emphasize 
107 
 
pharmacogenetic testing in attempt to assess which pharmaceutical treatments are most 
likely to yield positive results based on genetic variation; however, further emphasis of 
gene x environment interactions is consistent with evidence that pharmaceutical 
treatments combined with therapy yield the most significant improvements.  
Identifying traits associated with decreased responsiveness to social support and 
positive social experiences could inform interventions that modify these tendencies, 
enhancing the benefits of social support. There is some evidence that mindfulness 
training can reduce some tendencies such as negativity bias, which are associated with 
depression symptoms (Kiken & Shook, 2011). Identifying these traits could also help 
identify individuals who may benefit more from less socially-oriented interventions. 
Socially-oriented therapy such as Cognitively-Based Compassion Training (CBCT) is 
effective in helping some couples in which one struggles with depression, so evidence 
regarding individual differences in social responsiveness may guide treatments focusing 
on maximizing the benefit people get from their social connections (Aguilar-Raab et al., 
2019).  
Because common treatments for mood and anxiety disorders involve both 
pharmaceutical and therapeutic approaches, understanding the interplay between 
biological systems and social experiences is key to effective person-centered treatment 
(Bockting et al., 2018). Future research investigating candidate biological systems may 
benefit from focusing on systems that are commonly targeted by pharmacological 
depression treatments such as the serotonin system (Blier & El Mansari, 2013), or using 
more exploratory approaches such as Genome Wide Association Studies to discover 
other biological systems that may play a role (Maul et al., 2020).  
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Although investigations of genetic variation can be helpful for understanding 
individual differences in biological systems that may play a role in behavioral 
phenotypes, associations between genetics and complex behaviors are minimal and 
indirect (Turkheimer, 2000). Current paradigms for testing genetic associations with 
mental health outcomes have not been successful at explaining substantial individual 
differences in mental health. This is likely because genetic effects are so small and so 
many other factors become more important throughout a person’s life. Understanding 
individual differences in biological systems relevant to depression symptoms may require 
studying the current state of that biological system by measuring serum or neural levels 
of relevant transmitters instead of variation in the genetic code. Drug administration 




CHAPTER 5: SUMMARY 
This dissertation addressed questions of interactions between social experiences 
and individual differences in social responsiveness traits and oxytocin system genetic 
variation in depression symptom severity. A study with 1,128 participants using validated 
measures of perceived social support, discrimination, childhood trauma, and sexual 
objectification allowed comparison of relative contribution of these experiences to 
depression symptom severity with high reliability. To answer questions about traits that 
moderate these effects, this study included tests of interactions with a variety of social 
responsiveness traits and a latent variable of Social Responsiveness. A systematic review 
of oxytocin system genetic variation associated with depression and subsequent study 
testing a polygenic score in association with depression symptom severity and social 
responsiveness traits addressed questions of the potential role of genetic variation in the 
oxytocin system in depression symptom severity in context of social experiences. 
Perceived social support and discrimination are stronger predictors of depression 
symptom severity than childhood trauma or sexual objectification. Associations of 
perceived social support and discrimination with depression symptom severity are also 
moderated by social responsiveness traits. Higher perceived social support was only 
associated with lower depression symptom severity for people with higher rejection 
sensitivity or higher alexithymia. A latent Social Responsiveness factor including 
rejection sensitivity, need to belong, self-monitoring, and dispositional empathy had good 
fit and moderated associations of perceived social support and discrimination with 




A systematic review identified 33 studies investigating associations between 
genetic variation in the oxytocin system and depression. Most (21) only investigated one 
genetic variant, only three had sample sizes above the recommended threshold of 1,000 
participants, and some (9) used dichotomous criteria for depression diagnosis or suicide 
status, although most used a continuous variable of depression symptom severity. Many 
of the genetic variants tested were not associated with depression in many of these 
studies, and several of the significant effects identified were only present after 
considering social environmental context. Genetic variation in the oxytocin receptor gene 
was the most studied, and rs53576 was by far the most common SNP.  
A polygenic score of the 10 SNPs with the strongest evidence for an association 
with depression and social responsiveness was not associated with depression, rejection 
sensitivity, need to belong, self-monitoring, alexithymia, dispositional empathy, or a 
latent Social Responsiveness factor. The polygenic score did moderate an association 
between a net social experiences score aggregating perceived social support, childhood 
trauma, perceived discrimination, and sexual objectification with depression symptom 
severity. However, this moderating effect was not robust to adjustment for multiple 
testing and did not occur for associations between any of the individual experiences and 
depression symptom severity. The polygenic score also played no role in models 
connecting social network size, perceived social support, and depression symptom 
severity. 
In addition to evidence regarding the roles of social experiences and traits in 
depression symptom severity, the combination of work in this dissertation compiles a 
useful review and empirical evidence to give the most comprehensive evidence available 
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regarding a potential role of genetic variation in the oxytocin system in depression 
symptoms, including a consideration of the context of social experience. Investigating 
several different social experiences simultaneously and considering a variety of social 
responsiveness traits yielded new information about how these factors relate to one 
another in depression symptom severity. This is the first known study to capture an 
underlying Social Responsiveness factor using a latent variable with traits like rejection 
sensitivity, need to belong, self-monitoring, and dispositional empathy as indicators. By 
reviewing studies testing associations between genetic variation in the oxytocin system 
and depression symptom severity and testing an association with a polygenic score, we 
were unable to show any strong or robust associations. This aligns with previous well-
powered studies showing a lack of association between oxytocin-related genetic variation 
and depression (e.g. Tollenaar, Molendijk, Penninx, Milaneschi, & Antypa, 2017). The 
potential role of genetic variation in the oxytocin system in moderating associations 
between social experience and depression symptom severity is weak and difficult to 
capture, at best. This aligns with recent shifts in behavior genetics work acknowledging 
the limitations of candidate gene associations and difficulty in capturing reliable genetic 
associations with complex behavioral phenotypes (Duncan & Keller, 2011). 
The evidence presented in this dissertation benefits from strong theoretical 
groundwork, a combination of a systematic review to carefully inform decisions and 
empirical evidence with a large sample size, validated instruments, and strong 
methodology. Approaching depression symptom severity with questions about social 
experiences in context of social responsiveness traits and genetic variation in the oxytocin 
system provides rich information acknowledging elements of individual differences that 
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are genetic, and those that arise in other ways. A sample size of 1,128 participants 
provides strong statistical power for testing structural equation modeling frameworks and 
is large enough to test genetic questions as well.  
The studies conducted are limited in their scope and certain methodological 
limitations also lead us to recommend interpreting results with caution. Symptoms of 
depression tend to be closely related to symptoms of anxiety, and measuring anxiety, as 
well as a different measure of depression that provides more information about specific 
symptom profiles rather than a single dimensional measure would allow for more 
understanding about specifically what elements of depression are associated with certain 
experiences and individual differences. There are other social experiences (such as 
parenting style and relationship satisfaction) that are also associated with depression 
symptom severity and may have been useful to compare, as well as not-specifically-
social experiences such as medical struggles and financial struggles that may provide 
information about the distinction. For the final paper, using candidate gene association 
studies has significant limitations (Duncan & Keller, 2011). 
The current work contributes to understanding individual differences in responses 
to social experiences in the etiology of depression symptoms; however, more work is 
needed to understand potential applications of the current evidence. Understanding that 
perceived social support is such a strong predictor of depression symptom severity may 
suggest that interventions aimed at improving social skills, enhancing social support, 
increasing opportunity for social contact, and addressing maladaptive social cognition 
may be particularly useful for reducing symptoms of depression (Masi et al., 2011). 
Therapeutic approaches focused on healing wounds from discrimination (Comas-Díaz, 
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2016) may also be particularly valuable, based on the strong contribution of 
discrimination experiences to variation in depression symptom severity in this work. 
Future work should compare the efficacy of social-focused therapeutic interventions 
across individual differences in Social Responsiveness, rejection sensitivity, and 
alexithymia. 
We found evidence that there is shared variance among rejection sensitivity, need 
to belong, self-monitoring, and dispositional empathy that is useful in explaining 
individual differences in the association between perceived social support and 
discrimination with depression symptom severity. However, the mechanism for this 
underlying Social Responsiveness factor is not yet characterized. The Social 
Responsiveness factor was not associated with genetic variation in the oxytocin system in 
the current work, so if individual differences in biological systems explain some of this 
shared variance, it is either difficult to detect at the level of genetic variation in a single 
system, and/or a different biological system is crucial. Alexithymia moderates the 
association between perceived social support and depression symptom severity, so this 
may also suggest that high alexithymia plays a particular role in risk of depression 
symptoms for people suffering from low social support.  
Future research should test the specificity of the Social Responsiveness latent 
variable by including other traits including sensory processing sensitivity and 
introversion, which are related and relevant to individual differences in social processing 
(Aron & Aron, 1997). This latent variable should also be tested in association with 
existing social responsiveness measures (which are typically used to assess symptoms of 
autism) and potentially used to create a more inclusive self-report instrument to measure 
114 
 
Social Responsiveness (Hus et al., 2013). To characterize the mechanism of the 
underlying Social Responsiveness factor, we recommend testing its association with 
other measures that correlate with oxytocin neurotransmission, including endogenous 
oxytocin levels (Bakos, Srancikova, Havranek, & Bacova, 2018), and testing if intranasal 
oxytocin administration has any effect on measures of Social Responsiveness traits, since 
it has been shown to increase experiences of attachment (Bernaerts et al., 2017). 
Furthermore, other biological systems such as the serotonin system that have implications 
for social responsiveness (Sullivan, Gervais, Brock, & Stoltenberg, 2020) and depression 
(Underwood et al., 2018) would be important considerations, and GWAS may be helpful 
in identifying other biological systems that may have implications for the mechanism of 






Supplementary Table 1. Studies testing an association between oxytocin system 
genetic variation and depression. 
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